Peter Carroll, MD, MPH
Professor
Urology
School of Medicine

My research interests include identifying clinical and pathologic determinants of prostate cancer detection, recurrence, progression, and mortality; discovering novel biomarkers for prostate cancer diagnostics and prognostics, developing evidence-based guidelines for improved management of prostate cancer including surveillance alone, refining the use and outcomes of robotic surgery for prostate cancer, and examining the impact of lifestyle on prostate cancer induction and progression.…

Education & Training

Show all (4) Hide

• Diversity, Equity, and Inclusion Champion Training University of California, San Francisco 01/2021
• MPH University of California, Berkeley 06/2008
• Urologic Oncology Memorial Sloan Kettering Cancer Center 06/1986
• Residency School of Medicine -Urology University of California, San Francisco

Websites

Show all (1) Hide

• Clinical Profile at UCSF Medical Center (ucsfhealth.org)

Grants and Projects

Show all (7) Hide

• Cancer Center Support Grant, NIH, 1999-2023
• UCSF KURe Career Development Program, NIH, 2008-2020
• Effectiveness of Early Stage Prostate Cancer Treatment, NIH, 2009-2012
• Male Reproductive Health Research Career Development Program, NIH, 2006-2012
• Ucsf Prostate Cancer Spore, NIH, 2000-2010
• Molecular Effects of Nutrition Supplements in Prostate, NIH, 2003-2009
• Active Surveillance for Early Stage Prostate Cancer: Selection, Monitoring, NIH, 2006-2007

Publications (884)

Top publication keywords:
Androgen AntagonistsProstateRisk AssessmentNeoplasm Recurrence, LocalNeoplasm StagingBiomarkers, TumorProstatic NeoplasmsProstate-Specific AntigenProstatectomyMaleKallikreinsWatchful WaitingNeoplasm GradingAntineoplastic Agents, HormonalBiopsy

• Time is on our side - rethinking the concept of time to treatment for prostate cancer.
  Nature reviews. Urology 2024 Palmer NR, Carroll PR, Washington SL
• Targeted Biopsy Is Sufficient for Men on Active Surveillance for Early-Stage Prostate Cancer.
  The Journal of urology 2024 Fakunle MO, Cowan JE, Washington SL, Shinohara K, Nguyen HG, Carroll PR
• Legends in Urology v31I05.
  The Canadian journal of urology 2024 Carroll PR
• Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of Life.
  JAMA network open 2024 Patel SA, Patil D, Smith J, Saigal CS, Litwin MS, Hu JC, Cooperberg MR, Carroll PR, Klein EA, Kibel AS, Andriole GL, Han M, Michalski JM, Wood DP, Hembroff LA, Spratt DE, Wei JT, Sandler HM, Hamstra …
• Determining Long-term Prostate Cancer Outcomes for Active Surveillance Patients Without Early Disease Progression: Implications for Slowing or Stopping Surveillance.
  European urology oncology 2024 Shee K, Nie J, Cowan JE, Wang L, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR

Show all (879 more) Hide

• Reevaluating the Definition of "Clinically Significant" Prostate Cancer as Grade Groups 2-5: An Imperative for Improved Risk Stratification.
  The Journal of urology 2024 Carlsson SV, Carroll PR, Hamdy FC
• The impact of benign tissue within cancerous regions in the prostate: Characterizing sparse and dense prostate cancers on whole-mount histopathology and on multiparametric MRI.
  Magnetic resonance imaging 2024 Starobinets O, Simko JP, Gibbons M, Kurhanewicz J, Carroll PR, Noworolski SM
• Delayed definitive management of localized prostate cancer: what do we know?
  Prostate cancer and prostatic diseases 2024 Mohamad O, Li YR, Feng F, Hong JC, Wong A, El Kouzi Z, Shelan M, Zilli T, Carroll P, Roach M
• Pharmacokinetic Comparison of Selective Prostatic Arterial and Intravenous PSMA PET/CT Radioligand Infusions in Primary Prostatic Adenocarcinoma.
  Radiology 2024 Kohlbrenner R, Wu X, Nguyen HG, Cooperberg MR, Chakravarty T, Carroll PR, Hope TA
• De-escalation of Monitoring in Active Surveillance for Prostate Cancer: Results from the GAP3 Consortium.
  European urology oncology 2024 Tohi Y, Sahrmann JM, Arbet J, Kato T, Lee LS, Peacock M, Ginsburg K, Pavlovich C, Carroll P, Bangma CH, Sugimoto M, Boutros PC, Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
• Prostate-Specific Antigen Values in Transgender Women Receiving Estrogen.
  JAMA 2024 Nik-Ahd F, De Hoedt AM, Butler C, Anger JT, Carroll PR, Cooperberg MR, Freedland SJ
• Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical Registry.
  European urology oncology 2024 Bangma C, Doan P, Zhu L, Remmers S, Nieboer D, Helleman J, Roobol MJ, Sugimoto M, Chung BH, Lee LS, Frydenberg M, Klotz L, Peacock M, Perry A, Bjartell A, Rannikko A, Van Hemelrijck M, Dasgupta P, …
• Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.
  JAMA 2024 Newcomb LF, Schenk JM, Zheng Y, Liu M, Zhu K, Brooks JD, Carroll PR, Dash A, de la Calle CM, Ellis WJ, Filson CP, Gleave ME, Liss MA, Martin F, McKenney JK, Morgan TM, Tretiakova MS, Wagner AA, Nelson…
• Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage.
  Histopathology 2024 Nguyen JK, Harik LR, Klein EA, Li J, Corrigan D, Liu S, Chan E, Hawley S, Auman H, Newcomb LF, Carroll PR, Cooperberg MR, Filson CP, Simko JP, Nelson PS, Tretiakova MS, Troyer D, True LD, Vakar-Lopez …
• Morphologic patterns observed in prostate biopsy cases with discrepant grade group and molecular risk classification.
  The Prostate 2024 Greenland NY, Cooperberg MR, Carroll PR, Cowan JE, Simko JP, Stohr BA, Chan E
• Plant-Based Diets and Disease Progression in Men With Prostate Cancer.
  JAMA network open 2024 Liu VN, Van Blarigan EL, Zhang L, Graff RE, Loeb S, Langlais CS, Cowan JE, Carroll PR, Chan JM, Kenfield SA
• Evaluation of URO17® to improve non-invasive detection of bladder cancer.
  Urologic oncology 2024 Porten SP, Wang EY, Vohra P, Carroll PR, Jahanfard S, Kim NW
• The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer.
  Cancer 2024 Braun AE, Chan JM, Neuhaus J, Cowan JE, Kenfield SA, Van Blarigan EL, Tenggara I, Broering JM, Simko JP, Carroll PR, Cooperberg MR
• High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker.
  Scientific reports 2024 Liu S, Hawley SJ, Kunder CA, Hsu EC, Shen M, Westphalen L, Auman H, Newcomb LF, Lin DW, Nelson PS, Feng Z, Tretiakova MS, True LD, Vakar-Lopez F, Carroll PR, Simko J, Gleave ME, Troyer DA, McKenney JK…
• Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study.
  BMC cancer 2023 Guan A, Santiago-Rodríguez EJ, Chung BI, Shim JK, Allen L, Kuo MC, Lau K, Loya Z, Brooks JD, Cheng I, DeRouen MC, Frosch DL, Golden T, Leppert JT, Lichtensztajn DY, Lu Q, Oh D, Sieh W, Wadhwa M, …
• The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort.
  European urology oncology 2023 Shee K, Cowan JE, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR
• Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panel.
  European journal of nuclear medicine and molecular imaging 2023 Berrens AC, Scheltema M, Maurer T, Hermann K, Hamdy FC, Knipper S, Dell'Oglio P, Mazzone E, de Barros HA, Sorger JM, van Oosterom MN, Stricker PD, van Leeuwen PJ, Rietbergen DDD, Valdes Olmos RA, …
• Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer.
  Histopathology 2023 Greenland NY, Cowan JE, Stohr BA, Simko JP, Carroll PR, Chan E
• Effect of a Home-based Walking Intervention on Cardiopulmonary Fitness and Quality of Life Among Men with Prostate Cancer on Active Surveillance: The Active Surveillance Exercise Randomized Controlled Trial.
  European urology oncology 2023 Van Blarigan EL, Kenfield SA, Olshen A, Panchal N, Encabo K, Tenggara I, Graff RE, Bang AS, Shinohara K, Cooperberg MR, Carroll PR, Jones LW, Winters-Stone K, Luke A, Chan JM
• What is the most effective and safest Non-steroidal anti-inflammatory drug for treating osteoarthritis in patients with comorbidities?
  Expert opinion on drug metabolism & toxicology 2023 Geczy QE, Thirumaran AJ, Carroll PR, McLachlan AJ, Hunter DJ
• Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer.
  European urology 2023 Herlemann A, Cowan JE, Washington SL, Wong AC, Broering JM, Carroll PR, Cooperberg MR
• Ten-year work burden after prostate cancer treatment.
  Cancer medicine 2023 Washington SL, Lonergan PE, Cowan JE, Zhao S, Broering JM, Palmer NR, Hicks C, Cooperberg MR, Carroll PR
• Editorial Comment.
  Urology practice 2023 Carroll PR
• First-in-human Evaluation of a Prostate-specific Membrane Antigen-targeted Near-infrared Fluorescent Small Molecule for Fluorescence-based Identification of Prostate Cancer in Patients with High-risk Prostate Cancer Undergoing Robotic-assisted Prostatectomy.
  European urology oncology 2023 Nguyen HG, van den Berg NS, Antaris AL, Xue L, Greenberg S, Rosenthal JW, Muchnik A, Klaassen A, Simko JP, Dutta S, Sorger JM, Munster P, Carroll PR
• Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical Prostatectomy.
  European urology focus 2023 Sabbagh A, Tilki D, Feng J, Huland H, Graefen M, Wiegel T, Böhmer D, Hong JC, Valdes G, Cowan JE, Cooperberg M, Feng FY, Mohammad T, Shelan M, D'Amico AV, Carroll PR, Mohamad O
• Presurgical 68Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial.
  European urology 2023 Djaïleb L, Armstrong WR, Thompson D, Gafita A, Farolfi A, Rajagopal A, Grogan TR, Nguyen K, Benz MR, Hotta M, Barbato F, Ceci F, Schwarzenböck SM, Unterrainer M, Zacho HD, Juarez R, Cooperberg M, …
• Transcriptomic Heterogeneity of Expansile Cribriform and Other Gleason Pattern 4 Prostate Cancer Subtypes.
  European urology oncology 2023 Chappidi MR, Sjöström M, Greenland NY, Cowan JE, Baskin AS, Shee K, Simko JP, Chan E, Stohr BA, Washington SL, Nguyen HG, Quigley DA, Davicioni E, Feng FY, Carroll PR, Cooperberg MR
• Explainable ML models for a deeper insight on treatment decision for localized prostate cancer.
  Scientific reports 2023 Han JH, Lee S, Lee B, Baek OK, Washington SL, Herlemann A, Lonergan PE, Carroll PR, Jeong CW, Cooperberg MR
• Impact of Stress Urinary Incontinence After Radical Prostatectomy on Time to Intervention, Quality of Life and Work Status.
  Urology 2023 Braun AE, Washington SL, Cowan JE, Hampson LA, Carroll PR
• Barriers and confidence among colorectal and prostate cancer survivors participating in two behavioral intervention studies.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2023 Liu VN, Zuniga KB, Paciorek A, Zhang L, Chan JM, Carroll PR, Van Loon K, Laffan A, Venook A, Van Blarigan EL, Kenfield SA
• Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancer.
  Urologic oncology 2023 Baskin A, Cowan JE, Braun A, Lonergan PE, Mohamad O, Washington SL, Zhao S, Broering JM, Cooperberg MR, Breyer BN, Carroll PR
• Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 Patel P, Harmon S, Iseman R, Ludkowski O, Auman H, Hawley S, Newcomb LF, Lin DW, Nelson PS, Feng Z, Boyer HD, Tretiakova MS, True LD, Vakar-Lopez F, Carroll PR, Cooperberg MR, Chan E, Simko J, Fazli L…
• Prostate Cancer in Transgender Women in the Veterans Affairs Health System, 2000-2022.
  JAMA 2023 Nik-Ahd F, De Hoedt A, Butler C, Anger JT, Carroll PR, Cooperberg MR, Freedland SJ
• The Long-term Incidence and Quality of Life Outcomes Associated With Treatment-Related Toxicities of External Beam Radiotherapy for Prostate Cancer.
  Urology 2023 Lonergan PE, Baskin A, Greenberg SA, Mohamad O, Washington SL, Zhao S, Cowan JE, Broering JM, Nguyen HG, Cooperberg MR, Breyer BN, Carroll PR
• Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality.
  British journal of cancer 2023 Langlais CS, Graff RE, Van Blarigan EL, Neuhaus JM, Cowan JE, Broering JM, Carroll P, Kenfield SA, Chan JM
• Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin.
  Clinical genitourinary cancer 2023 Jindal T, Zhang L, Deshmukh P, Reyes K, Chan E, Kumar V, Zhu X, Maldonado E, Feng S, Johnson M, Angelidakis A, Kwon D, Desai A, Borno HT, Bose R, Wong A, Hong J, Carroll P, Meng M, Porten S, Aggarwal …
• A Novel Standardized Morbidity and Mortality Process to Promote Discourse, Improve Education, and Facilitate Practice Change: The M-PROVE Model.
  Urology practice 2023 Bowman M, Yang H, Ahn J, Carroll PR, Hampson LA
• Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-based vs Physical Exam-based Staging.
  The Journal of urology 2023 Chang K, Greenberg SA, Cowan JE, Parker R, Shee K, Washington SL, Nguyen HG, Shinohara K, Carroll PR, Cooperberg MR
• PSA density does not improve predictive accuracy of the UCSF-CAPRA score.
  The Prostate 2023 Parker R, Bell A, Chang K, Greenberg S, Washington SL, Cowan JE, Carroll PR, Cooperberg MR
• Seeing the unseen: how can we best identify transgender women within the Veterans Affairs healthcare system's electronic medical record?
  The journal of sexual medicine 2023 Nik-Ahd F, Waller J, De Hoedt AM, Garcia MM, Figueiredo JC, Carroll PR, Cooperberg MR, Freedland SJ
• Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States.
  The world journal of men's health 2023 Han JH, Herlemann A, Washington SL, Lonergan PE, Carroll PR, Cooperberg MR, Jeong CW
• Limited Relevance of the Very Low Risk Prostate Cancer Classification in the Modern Era: Results from a Large Institutional Active Surveillance Cohort.
  European urology 2023 Shee K, Cowan JE, Balakrishnan A, Escobar D, Chang K, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR
• Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer.
  European urology oncology 2023 Sabbagh A, Washington SL, Tilki D, Hong JC, Feng J, Valdes G, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, Böhmer D, Cowan JE, Cooperberg M, Feng FY, Roach M, Trock BJ, Partin AW, D'Amico AV, Carroll…
• Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 Tilki D, Chen MH, Wu J, Huland H, Graefen M, Mohamad O, Cowan JE, Feng FY, Carroll PR, D'Amico AV
• The natural history of a delayed detectable PSA after radical prostatectomy.
  Prostate cancer and prostatic diseases 2023 Szymaniak JA, Washington SL, Cowan JE, Cooperberg MR, Lonergan PE, Nguyen HG, Meng MV, Carroll PR
• Prostate cancer lesion detection, volume quantification and high-grade cancer differentiation using cancer risk maps derived from multiparametric MRI with histopathology as the reference standard.
  Magnetic resonance imaging 2023 Gibbons M, Simko JP, Carroll PR, Noworolski SM
• Protocol for a 4-arm randomized controlled trial testing remotely delivered exercise-only, diet-only, and exercise + diet interventions among men with prostate cancer treated with radical prostatectomy (Prostate 8-II).
  Contemporary clinical trials 2023 Van Blarigan EL, Chan JM, Sanchez A, Zhang L, Winters-Stone K, Liu V, Macaire G, Panchal N, Graff RE, Tenggara I, Luke A, Simko JP, Cooperberg MR, Carroll PR, Kenfield SA
• Use of Voice Recordings in the Consultation of Patients Seeking Genital Gender-Affirming Surgery: An Opportunity for Broader Application Throughout Surgery?
  Journal of surgery and research 2022 Smith SM, Stelmar J, Lee G, Carroll PR, Garcia MM
• Health Literacy and Appropriateness of Self-Care and Pain Management in Osteoarthritis: An Understanding of the Patient's Perspective.
  Arthritis care & research 2022 Hunter DJ, McLachlan AJ, Carroll PR, Wakefield TAN, Stosic R
• Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low- and very-low risk prostate cancer.
  Cancer medicine 2022 Guan A, Shim JK, Allen L, Kuo MC, Lau K, Loya Z, Brooks JD, Carroll PR, Cheng I, Chung BI, DeRouen MC, Frosch DL, Golden T, Leppert JT, Lichtensztajn DY, Lu Q, Oh DL, Sieh W, Wadhwa M, Gomez SL, …
• Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance Study.
  Nutrition and cancer 2022 Schenk JM, Liu M, Neuhouser ML, Newcomb LF, Zheng Y, Zhu K, Brooks JD, Carroll PR, Dash A, Ellis WJ, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Wagner AA, Lin DW
• Prostate-Specific Antigen Screening in Transgender Patients.
  European urology 2022 Nik-Ahd F, Jarjour A, Figueiredo J, Anger JT, Garcia M, Carroll PR, Cooperberg MR, Vidal AC, Freedland SJ
• Emulation of a target trial with sustained treatment strategies: an application to prostate cancer using both inverse probability weighting and the g-formula.
  European journal of epidemiology 2022 Smith LH, García-Albéniz X, Chan JM, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR, Hernán MA
• Cost-effectiveness analysis of primary treatments for localised prostate cancer: A population-based Markov analysis using real-world evidence.
  European journal of cancer care 2022 Weng X, Zhong L, Xiang P, Li Y, Paciorek A, Dong L, Broering J, Carroll PR, Sanda M, Wilson L
• Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading, but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort. Reply.
  The Journal of urology 2022 Carroll P
• Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort.
  The Journal of urology 2022 Shee K, Washington SL, Cowan JE, de la Calle CM, Baskin AS, Chappidi MR, Escobar D, Nguyen HG, Cooperberg MR, Carroll PR
• Postdiagnostic Inflammatory, Hyperinsulinemic, and Insulin-Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2022 Langlais CS, Graff RE, Van Blarigan EL, Kenfield SA, Neuhaus J, Tabung FK, Cowan JE, Broering JM, Carroll P, Chan JM
• Risk of progression following a negative biopsy in prostate cancer active surveillance.
  Prostate cancer and prostatic diseases 2022 Beckmann K, Santaolalla A, Sugimoto M, Carroll P, Rubio J, Villers A, Bjartell A, Morgan T, Dasgupta P, Van Hemelrijck M, Elhage O, Movember Foundation’s Global Action Plan Prostate Cancer Active …
• Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue.
  Urology 2022 Andolfi C, Vickers AJ, Cooperberg MR, Carroll PR, Cowan JE, Paner GP, Helfand BT, Liauw SL, Eggener SE
• Adverse Pathological Findings at Radical Prostatectomy following Active Surveillance: Results from the Movember GAP3 Cohort.
  Cancers 2022 Marenghi C, Qiu Z, Helleman J, Nieboer D, Rubio-Briones J, Carroll PR, Lee LS, Valdagni R, Boutros PC, Nicolai N, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) …
• Medium Term Outcomes of Focal Cryoablation for Intermediate and High Risk Prostate Cancer: MRI and PSA are Not Predictive of Residual or Recurrent Disease.
  Urologic oncology 2022 Baskin A, Charondo LB, Balakrishnan A, Cowan JE, Cooperberg MR, Carroll PR, Nguyen H, Shinohara K
• Patient engagement in a mobile health intervention to improve preparedness for prostate biopsy.
  Urologic oncology 2022 Balakrishnan AS, Nguyen HG, Shinohara K, Carroll PR, Odisho AY
• Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance.
  The Journal of urology 2022 Filson CP, Zhu K, Huang Y, Zheng Y, Newcomb LF, Williams S, Brooks JD, Carroll PR, Dash A, Ellis WJ, Gleave ME, Liss MA, Martin F, McKenney JK, Morgan TM, Wagner AA, Sokoll LJ, Sanda MG, Chan DW, Lin …
• Development and Service Evaluation of an ad hoc Virtual Arthroplasty Clinic during COVID-19: Experiences from Irish National Orthopaedic Hospital.
  Malaysian orthopaedic journal 2022 Murphy B, Carroll P, Daly R, McLaverty A, Keogh P, O'Byrne J, Cashman J
• Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative.
  European urology open science 2022 Remmers S, Helleman J, Nieboer D, Trock B, Hyndman ME, Moore CM, Gnanapragasam V, Shiong Lee L, Elhage O, Klotz L, Carroll P, Pickles T, Bjartell A, Robert G, Frydenberg M, Sugimoto M, Ehdaie B, …
• Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance.
  Cancer medicine 2022 Brady L, Newcomb LF, Zhu K, Zheng Y, Boyer H, Sarkar N, McKenney JK, Brooks JD, Carroll PR, Dash A, Ellis WJ, Filson CP, Gleave ME, Liss MA, Martin F, Morgan TM, Thompson IM, Wagner AA, Pritchard CC, …
• Editorial Comment.
  The Journal of urology 2022 Carroll PR
• The effect of preoperative membranous urethral length on likelihood of postoperative urinary incontinence after robot-assisted radical prostatectomy.
  Prostate cancer and prostatic diseases 2022 Greenberg SA, Cowan JE, Lonergan PE, Washington SL, Nguyen HG, Zagoria RJ, Carroll PR
• Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 Trial.
  Advances in radiation oncology 2022 Shee K, de la Calle CM, Chang AJ, Wong AC, Feng FY, Gottschalk AR, Carroll PR, Nguyen HG
• Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database.
  The Prostate 2022 Beckmann KR, Bangma CH, Helleman J, Bjartell A, Carroll PR, Morgan T, Nieboer D, Santaolalla A, Trock BJ, Valdagni R, Roobol MJ, Global Action Plan Active Surveillance Prostate Cancer [G.A.P.3] …
• Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis.
  Human pathology 2022 Ruder S, Gao Y, Ding Y, Bu P, Miles B, De Marzo A, Wheeler T, McKenney JK, Auman H, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave M, Platz E, Trock B, Han M, Sayeeduddin M, True LD, …
• Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 Chan E, McKenney JK, Hawley S, Corrigan D, Auman H, Newcomb LF, Boyer HD, Carroll PR, Cooperberg MR, Klein E, Fazli L, Gleave ME, Hurtado-Coll A, Simko JP, Nelson PS, Thompson IM, Tretiakova MS, …
• Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states.
  Nature communications 2022 Song H, Weinstein HNW, Allegakoen P, Wadsworth MH, Xie J, Yang H, Castro EA, Lu KL, Stohr BA, Feng FY, Carroll PR, Wang B, Cooperberg MR, Shalek AK, Huang FW
• Osteoarthritis management: Does the pharmacist play a role in bridging the gap between what patients actually know and what they ought to know? Insights from a national online survey.
  Health expectations : an international journal of public participation in health care and health policy 2022 McLachlan AJ, Carroll PR, Hunter DJ, Wakefield TAN, Stosic R
• The Natural History of Untreated Biopsy Grade Group Progression and Delayed Definitive Treatment for Men on Active Surveillance for Early-Stage Prostate Cancer.
  The Journal of urology 2022 Chappidi MR, Bell A, Cowan JE, Greenberg SA, Lonergan PE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR
• Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium.
  European urology open science 2022 Olivier J, Li W, Nieboer D, Helleman J, Roobol M, Gnanapragasam V, Frydenberg M, Sugimoto M, Carroll P, Morgan TM, Valdagni R, Rubio-Briones J, Robert G, Stricker P, Hayen A, Schoots I, Haider M, …
• Molecular risk classifier score and biochemical recurrence risk are associated with cribriform pattern type in Gleason 3+4=7 prostate cancer.
  Investigative and clinical urology 2022 Greenland NY, Cooperberg MR, Wong AC, Chan E, Carroll PR, Simko JP, Stohr BA
• Development and evaluation of an interprofessional student-led influenza vaccination clinic for medical, nursing and pharmacy students.
  Pharmacy practice 2021 Carroll PR, Hanrahan J
• Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer.
  The Journal of urology 2021 Lonergan PE, Washington SL, Cowan JE, Zhao S, Broering JM, Cooperberg MR, Carroll PR
• Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort.
  The Journal of urology 2021 Waisman Malaret AJ, Chang P, Zhu K, Zheng Y, Newcomb LF, Liu M, McKenney JK, Brooks JD, Carroll P, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Lin DW, Wagner AA
• Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.
  HGG advances 2021 Jiang Y, Meyers TJ, Emeka AA, Cooley LF, Cooper PR, Lancki N, Helenowski I, Kachuri L, Lin DW, Stanford JL, Newcomb LF, Kolb S, Finelli A, Fleshner NE, Komisarenko M, Eastham JA, Ehdaie B, Benfante N,…
• Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database.
  European urology open science 2021 Beckmann K, Santaolalla A, Helleman J, Carroll P, Ha Chung B, Shiong Lee L, Perry A, Rubio-Briones J, Sugimoto M, Trock B, Valdagni R, Dasgupta P, Van Hemelrijck M, Elhage O, Movember Foundation's …
• Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.
  JAMA oncology 2021 Hope TA, Eiber M, Armstrong WR, Juarez R, Murthy V, Lawhn-Heath C, Behr SC, Zhang L, Barbato F, Ceci F, Farolfi A, Schwarzenböck SM, Unterrainer M, Zacho HD, Nguyen HG, Cooperberg MR, Carroll PR, …
• Identification of prostate cancer using multiparametric MR imaging characteristics of prostate tissues referenced to whole mount histopathology.
  Magnetic resonance imaging 2021 Gibbons M, Starobinets O, Simko JP, Kurhanewicz J, Carroll PR, Noworolski SM
• Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer.
  Cancer 2021 Kirk PS, Zhu K, Zheng Y, Newcomb LF, Schenk JM, Brooks JD, Carroll PR, Dash A, Ellis WJ, Filson CP, Gleave ME, Liss M, Martin F, McKenney JK, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW, Gore…
• Active surveillance in intermediate-risk prostate cancer with PSA 10-20 ng/mL: pathological outcome analysis of a population-level database.
  Prostate cancer and prostatic diseases 2021 Lonergan PE, Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR
• Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium.
  The Journal of urology 2021 Chang P, Wagner AA, Regan MM, Smith JA, Saigal CS, Litwin MS, Hu JC, Cooperberg MR, Carroll PR, Klein EA, Kibel AS, Andriole GL, Han M, Partin AW, Wood DP, Crociani CM, Greenfield TK, Patil D, …
• Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume.
  Urology 2021 Vertosick EA, Zappala S, Punnen S, Hugosson J, Boorjian SA, Haese A, Carroll P, Cooperberg M, Bjartell A, Lilja H, Vickers AJ
• Natural history of an immediately detectable PSA following radical prostatectomy in a contemporary cohort.
  The Prostate 2021 Lonergan PE, Cowan JE, Washington SL, Greenberg SA, Nguyen HG, Carroll PR
• Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS Cohort.
  Urology practice 2021 Waisman Malaret AJ, Chang P, Newcomb L, Faino A, Zheng Y, Zhu K, McKenney JK, Brooks JD, Dash A, Ellis WJ, Filson CP, Gleave M, Liss M, Martin FM, Morgan T, Carroll P, Nelson P, Lin DW, Wagner AA
• Association of Age With Risk of Adverse Pathological Findings in Men Undergoing Delayed Radical Prostatectomy Following Active Surveillance.
  Urology 2021 de la Calle CM, Shee K, Chu CE, Cowan JE, Nguyen HG, Carroll PR
• A bicentric retrospective analysis of clinical utility of 18F-fluciclovine PET in biochemically recurrent prostate cancer following primary radiation therapy: is it helpful in patients with a PSA rise less than the Phoenix criteria?
  European journal of nuclear medicine and molecular imaging 2021 Salavati A, Gencturk M, Koksel Y, Schik AN, Carroll PR, Feng FY, Rowe SP, Lawhn-Heath C, Hope TA, Froelich JW
• Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 Tilki D, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, Böhmer D, Mohamad O, Cowan JE, Feng FY, Carroll PR, Trock BJ, Partin AW, D'Amico AV
• Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing.
  JCO precision oncology 2021 Chen E, Cario CL, Leong L, Lopez K, Márquez CP, Li PS, Oropeza E, Tenggara I, Cowan J, Simko JP, Kageyama R, Wells DK, Chan JM, Friedlander T, Aggarwal R, Paris PL, Feng F, Carroll PR, Witte JS
• Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen.
  The Journal of urology 2021 Greenberg SA, Washington SL, Lonergan PE, Cowan JE, Baskin AS, Nguyen HG, Odisho AY, Simko JP, Carroll PR
• SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study.
  Cancers 2021 Maggi M, Del Giudice F, Falagario UG, Cocci A, Russo GI, Di Mauro M, Sepe GS, Galasso F, Leonardi R, Iacona G, Carroll PR, Cooperberg MR, Porreca A, Ferro M, Lucarelli G, Terracciano D, Cormio L, …
• Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes.
  International journal of molecular sciences 2021 Salciccia S, Capriotti AL, Laganà A, Fais S, Logozzi M, De Berardinis E, Busetto GM, Di Pierro GB, Ricciuti GP, Del Giudice F, Sciarra A, Carroll PR, Cooperberg MR, Sciarra B, Maggi M
• Reply by Authors.
  The Journal of urology 2021 Pienta KJ, Gorin MA, Rowe SP, Carroll PR, Pouliot F, Probst S, Saperstein L, Preston MA, Alva AS, Patnaik A, Durack JC, Stambler N, Lin T, Jensen J, Wong V, Siegel BA, Morris MJ
• Post-diagnostic coffee and tea consumption and risk of prostate cancer progression by smoking history.
  Cancer causes & control : CCC 2021 Langlais CS, Chan JM, Kenfield SA, Cowan JE, Graff RE, Broering JM, Carroll P, Van Blarigan EL
• Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer.
  European urology 2021 Chu CE, Alshalalfa M, Sjöström M, Zhao SG, Liu Y, Chou J, Herlemann A, Mahal B, Kishan AU, Spratt DE, Cooperberg M, Small E, Wong A, Porten S, Hope TA, Ross AE, Davicioni E, Nguyen P, Karnes RJ, …
• Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Letter.
  The Journal of urology 2021 Gaylis FD, Cooperberg MR, Chen RC, Malin J, Loeb S, Witte JS, Carroll PR, Cohen ES, Dato PE, Lin DW, Zheng Y, Seibert TM, Setzler C, Wilt W, Gomez SL, Chan JML, Catalona WJ
• The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. Reply.
  The Journal of urology 2021 Carroll PR, Maggi M
• Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus.
  Urologic oncology 2021 Tan WP, Rastinehad AR, Klotz L, Carroll PR, Emberton M, Feller JF, George AK, Gill IS, Gupta RT, Katz AE, Lebastchi AH, Marks LS, Marra G, Pinto PA, Song DY, Sidana A, Ward JF, Sanchez-Salas R, …
• Cell-free DNA concentration and fragment size as a biomarker for prostate cancer.
  Scientific reports 2021 Chen E, Cario CL, Leong L, Lopez K, Márquez CP, Chu C, Li PS, Oropeza E, Tenggara I, Cowan J, Simko JP, Chan JM, Friedlander T, Wyatt AW, Aggarwal R, Paris PL, Carroll PR, Feng F, Witte JS
• A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY).
  The Journal of urology 2021 Pienta KJ, Gorin MA, Rowe SP, Carroll PR, Pouliot F, Probst S, Saperstein L, Preston MA, Alva AS, Patnaik A, Durack JC, Stambler N, Lin T, Jensen J, Wong V, Siegel BA, Morris MJ
• Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2021 Morris MJ, Rowe SP, Gorin MA, Saperstein L, Pouliot F, Josephson D, Wong JYC, Pantel AR, Cho SY, Gage KL, Piert M, Iagaru A, Pollard JH, Wong V, Jensen J, Lin T, Stambler N, Carroll PR, Siegel BA, …
• A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance.
  BMC urology 2021 Merriel SWD, Moon D, Dundee P, Corcoran N, Carroll P, Partin A, Smith JA, Hamdy F, Moore C, Ost P, Costello T
• Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer.
  European urology oncology 2021 Chu CE, Cowan JE, Lonergan PE, Washington SL, Fasulo V, de la Calle CM, Shinohara K, Westphalen AC, Carroll PR
• Feasibility and Acceptability of a Remotely Delivered, Web-Based Behavioral Intervention for Men With Prostate Cancer: Four-Arm Randomized Controlled Pilot Trial.
  Journal of medical Internet research 2020 Chan JM, Van Blarigan EL, Langlais CS, Zhao S, Ramsdill JW, Daniel K, Macaire G, Wang E, Paich K, Kessler ER, Beer TM, Lyons KS, Broering JM, Carroll PR, Kenfield SA, Winters-Stone KM
• Editorial Comment.
  The Journal of urology 2020 Carroll PR
• Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease.
  Scientific reports 2020 Smith R, Liu M, Liby T, Bayani N, Bucher E, Chiotti K, Derrick D, Chauchereau A, Heiser L, Alumkal J, Feiler H, Carroll P, Korkola JE
• A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer.
  European urology 2020 Jairath NK, Dal Pra A, Vince R, Dess RT, Jackson WC, Tosoian JJ, McBride SM, Zhao SG, Berlin A, Mahal BA, Kishan AU, Den RB, Freedland SJ, Salami SS, Kaffenberger SD, Pollack A, Tran P, Mehra R, …
• Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy.
  Urology 2020 Chu CE, Law L, Zuniga K, Lin TK, Tsourounis C, Rodriguez-Monguio R, Lazar A, Washington SL, Cooperberg MR, Greene KL, Carroll PR, Pruthi RS, Meng MV, Chen LL, Porten SP
• Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate.
  JAMA oncology 2020 Dess RT, Suresh K, Zelefsky MJ, Freedland SJ, Mahal BA, Cooperberg MR, Davis BJ, Horwitz EM, Terris MK, Amling CL, Aronson WJ, Kane CJ, Jackson WC, Hearn JWD, Deville C, DeWeese TL, Greco S, McNutt TR…
• Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer.
  The Journal of urology 2020 Cullen J, Lynch JA, Klein EA, Van Den Eeden SK, Carroll PR, Mohler JL, Knezevic D, Farrington TA, Lu R
• Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US.
  JAMA network open 2020 Washington SL, Jeong CW, Lonergan PE, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR
• The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide?
  The Journal of urology 2020 Chu CE, Cowan JE, Fasulo V, Washington SL, de la Calle C, Shoemaker J, Carroll PR
• Comparison of biopsy under-sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies.
  Cancer medicine 2020 Li W, Denton BT, Nieboer D, Carroll PR, Roobol MJ, Morgan TM, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium
• Reply by Authors.
  The Journal of urology 2020 Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW
• The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer.
  The Journal of urology 2020 Maggi M, Cowan JE, Fasulo V, Washington SL, Lonergan PE, Sciarra A, Nguyen HG, Carroll PR
• Editorial Comment.
  The Journal of urology 2020 Chu C, Carroll P
• Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology Outcomes.
  European urology 2020 Cooperberg MR, Cowan JE, Lindquist KJ, Kobayashi Y, Simko JP, Bengtsson H, Singh K, Ngo V, Avila A, Newcomb LF, Tretriakova M, Lin DW, Stone S, Carroll PR, Paris PL
• Assessment of Postprostatectomy Radiotherapy as Adjuvant or Salvage Therapy in Patients With Prostate Cancer: A Systematic Review.
  JAMA oncology 2020 Sachdev S, Carroll P, Sandler H, Nguyen PL, Wafford E, Auffenberg G, Schaeffer E, Roach M, Evans CP, Hussain M
• Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate.
  JCO precision oncology 2020 Hall WA, Fishbane N, Liu Y, Xu MJ, Davicioni E, Mahal BA, Den RB, Dess RT, Jackson WC, Wong AC, Schaeffer EM, Karnes RJ, Carroll PR, Cooperberg MR, Bismar TA, Kim HL, Klein EA, Davis JW, Ross AE, …
• Influence of pelvic lymph node dissection and node-positive disease on biochemical recurrence, secondary treatment, and survival after radical prostatectomy in men with prostate cancer.
  The Prostate 2020 Washington SL, Cowan JE, Herlemann A, Zuniga KB, Masic S, Nguyen HG, Carroll PR
• Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy.
  European urology oncology 2020 Fasulo V, Cowan JE, Maggi M, Washington SL, Nguyen HG, Shinohara K, Lazzeri M, Casale P, Carroll PR
• Natural language processing systems for pathology parsing in limited data environments with uncertainty estimation.
  JAMIA open 2020 Odisho AY, Park B, Altieri N, DeNero J, Cooperberg MR, Carroll PR, Yu B
• Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability.
  JAMA oncology 2020 Cooperberg MR, Zheng Y, Faino AV, Newcomb LF, Zhu K, Cowan JE, Brooks JD, Dash A, Gleave ME, Martin F, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Carroll PR, Lin DW
• Student-led interprofessional influenza vaccination clinic in a time of coronavirus.
  Medical education 2020 Hanrahan JR, Carroll PR
• Reply by Authors.
  The Journal of urology 2020 Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR
• Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category.
  The Prostate 2020 Greenland NY, Cowan JE, Chan E, Carroll PR, Stohr BA, Simko JP
• Clinical Utility of 4Kscore®, ExosomeDx™ and Magnetic Resonance Imaging for the Early Detection of High Grade Prostate Cancer.
  The Journal of urology 2020 de la Calle CM, Fasulo V, Cowan JE, Lonergan PE, Maggi M, Gadzinski AJ, Yeung RA, Saita A, Cooperberg MR, Shinohara K, Carroll PR, Nguyen HG
• A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer.
  BMC cancer 2020 Cario CL, Chen E, Leong L, Emami NC, Lopez K, Tenggara I, Simko JP, Friedlander TW, Li PS, Paris PL, Carroll PR, Witte JS
• How Often Does Magnetic Resonance Imaging Detect Prostate Cancer Missed by Transrectal Ultrasound?
  European urology focus 2020 Herlemann A, Overland MR, Washington SL, Cowan JE, Westphalen AC, Carroll PR, Nguyen HG, Shinohara K, Cooperberg MR
• False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial.
  European journal of nuclear medicine and molecular imaging 2020 Fendler WP, Calais J, Eiber M, Simko JP, Kurhanewicz J, Santos RD, Feng FY, Reiter RE, Rettig MB, Nickols NG, Kishan AU, PSMA PET Reader Group, Slavik R, Carroll PR, Lawhn-Heath C, Herrmann K, Czernin…
• Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry.
  Urologic oncology 2020 Borno HT, Cowan JE, Zhao S, Broering JM, Carroll PR, Ryan CJ
• Rapid Utilization of Telehealth in a Comprehensive Cancer Center as a Response to COVID-19: Cross-Sectional Analysis.
  Journal of medical Internet research 2020 Lonergan PE, Washington Iii SL, Branagan L, Gleason N, Pruthi RS, Carroll PR, Odisho AY
• Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer.
  European urology 2020 Chu CE, Lonergan PE, Washington SL, Cowan JE, Shinohara K, Westphalen AC, Carroll PR, Cooperberg MR
• Re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51.
  European urology 2020 Chu CE, Lonergan PE, Carroll PR
• Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer.
  The Journal of urology 2020 Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR
• Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons …
• The Relative Impact of Urinary and Sexual Function vs Bother on Health Utility for Men With Prostate Cancer.
  JNCI cancer spectrum 2020 Jeong CW, Herlemann A, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR
• Impact of 68Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2020 Fendler WP, Ferdinandus J, Czernin J, Eiber M, Flavell RR, Behr SC, Wu IK, Lawhn-Heath C, Pampaloni MH, Reiter RE, Rettig MB, Gartmann J, Murthy V, Slavik R, Carroll PR, Herrmann K, Calais J, Hope TA
• Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance Study.
  The Journal of urology 2020 Liss MA, Newcomb LF, Zheng Y, Garcia MP, Filson CP, Boyer H, Brooks JD, Carroll PR, Cooperberg MR, Ellis WJ, Gleave ME, Martin FM, Morgan T, Nelson PS, Wagner AA, Thompson IM, Lin DW
• Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel.
  Radiology 2020 Westphalen AC, McCulloch CE, Anaokar JM, Arora S, Barashi NS, Barentsz JO, Bathala TK, Bittencourt LK, Booker MT, Braxton VG, Carroll PR, Casalino DD, Chang SD, Coakley FV, Dhatt R, Eberhardt SC, …
• Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4.
  The Prostate 2020 Greenland NY, Cowan JE, Zhang L, Carroll PR, Chan E, Stohr BA, Simko JP
• Editorial Comment.
  The Journal of urology 2020 Carroll PR, Chu C
• Evaluation of a vaccination training program for pharmacy graduands in Australia.
  Currents in pharmacy teaching & learning 2020 Carroll PR, Chen Y, Vicheth P, Webber P, Hanrahan JR
• The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations.
  European urology 2020 Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR
• Reply by Authors.
  The Journal of urology 2020 Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW
• MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort.
  AJR. American journal of roentgenology 2020 Washington SL, Baskin AS, Ameli N, Nguyen HG, Westphalen AC, Shinohara K, Carroll PR
• Development and pilot evaluation of a personalized decision support intervention for low risk prostate cancer patients.
  Cancer medicine 2019 Belkora J, Chan JM, Cooperberg MR, Neuhaus J, Stupar L, Weinberg T, Broering JM, Tenggara I, Cowan JE, Rosenfeld S, Kenfield SA, Van Blarigan EL, Simko JP, Witte J, Carroll PR
• Understanding the Major Factors Affecting Response Shift Effects on Health-Related Quality of Life: What the Then-Test Measures in a Longitudinal Prostate Cancer Registry.
  Clinical genitourinary cancer 2019 Ten Ham RMT, Broering JM, Cooperberg MR, Carroll P, Wilson LS
• Active surveillance for intermediate-risk prostate cancer: yes, but for whom?
  Current opinion in urology 2019 Overland MR, Washington SL, Carroll PR, Cooperberg MR, Herlemann A
• African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study.
  The Journal of urology 2019 Schenk JM, Newcomb LF, Zheng Y, Faino AV, Zhu K, Nyame YA, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Filson CP, Gleave ME, Liss M, Martin FM, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW
• Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer.
  The Journal of urology 2019 Bjurlin MA, Carroll PR, Eggener S, Fulgham PF, Margolis DJ, Pinto PA, Rosenkrantz AB, Rubenstein JN, Rukstalis DB, Taneja SS, Turkbey B
• A GABAergic Maf-expressing interneuron subset regulates the speed of locomotion in Drosophila.
  Nature communications 2019 Babski H, Jovanic T, Surel C, Yoshikawa S, Zwart MF, Valmier J, Thomas JB, Enriquez J, Carroll P, Garcès A
• Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts.
  Cancer 2019 Lange JM, Laviana AA, Penson DF, Lin DW, Bill-Axelson A, Carlsson SV, Newcomb LF, Trock BJ, Carter HB, Carroll PR, Cooperberg MR, Cowan JE, Klotz LH, Etzioni RB
• Reply by Authors.
  The Journal of urology 2019 Gross MD, Sedrakyan A, Bianco FJ, Carroll PR, Daskivich TJ, Eggener SE, Ehdaie B, Fisher B, Gorin MA, Hunt B, Jiang H, Klein EA, Marinac-Dabic D, Montgomery JS, Polascik TJ, Priester AM, Rastinehad AR…
• SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate Cancer.
  The Journal of urology 2019 Gross MD, Sedrakyan A, Bianco FJ, Carroll PR, Daskivich TJ, Eggener SE, Ehdaie B, Fisher B, Gorin MA, Hunt B, Jiang H, Klein EA, Marinac-Dabic D, Montgomery JS, Polascik TJ, Priester AM, Rastinehad AR…
• Germline testing in those at risk of prostate cancer.
  The Canadian journal of urology 2019 Carroll PR, Witte JS, Parsons JK
• Hematuria Practice Guidelines That Explicitly Consider Harms and Costs.
  JAMA internal medicine 2019 Bauer SR, Carroll PR, Grady D
• Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop.
  The Journal of urology 2019 Weinstock C, Suzman D, Kluetz P, Baxley J, Viviano C, Ibrahim A, Jarow J, Sridhara R, Liu K, Carroll P, Eggener S, Hu JC, Hussain M, King M, Klein E, Kungel T, Makarov D, Pinto PA, Rini B, Roach M, …
• A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology in Men on Active Surveillance.
  The Journal of urology 2019 Kornberg Z, Cooperberg MR, Cowan JE, Chan JM, Shinohara K, Simko JP, Tenggara I, Carroll PR
• Identification and Characterization of Circulating Tumor Cells in Men Who have Undergone Prostatectomy for Clinically Localized, High Risk Prostate Cancer.
  The Journal of urology 2019 Friedlander TW, Welty C, Anantharaman A, Schonhoft JD, Jendrisak A, Lee J, Li P, Hough J, Stromlund A, Edwards M, Sangar S, Kobayashi Y, Simko J, Farrokhian N, Lindquist K, Greene S, Ontiveros P, Graf…
• Stability of a 17-Gene Genomic Prostate Score in Serial Testing of Men on Active Surveillance for Early Stage Prostate Cancer.
  The Journal of urology 2019 Cedars BE, Washington SL, Cowan JE, Leapman M, Tenggara I, Chan JM, Cooperberg MR, Carroll PR
• Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer.
  The Journal of urology 2019 Zuniga KB, Zhao S, Kenfield SA, Cedars B, Cowan JE, Van Blarigan EL, Broering JM, Carroll PR, Chan JM
• Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2019 Langlais CS, Cowan JE, Neuhaus J, Kenfield SA, Van Blarigan EL, Broering JM, Cooperberg MR, Carroll P, Chan JM
• Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance.
  Prostate cancer and prostatic diseases 2019 Herlemann A, Huang HC, Alam R, Tosoian JJ, Kim HL, Klein EA, Simko JP, Chan JM, Lane BR, Davis JW, Davicioni E, Feng FY, McCue P, Kim H, Den RB, Bismar TA, Carroll PR, Cooperberg MR
• Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts.
  European urology 2019 Drost FH, Nieboer D, Morgan TM, Carroll PR, Roobol MJ, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP) Consortium
• Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical Prostatectomy after an Initial Period of Surveillance.
  The Journal of urology 2019 Balakrishnan AS, Cowan JE, Cooperberg MR, Shinohara K, Nguyen HG, Carroll PR
• Guidelines should be assessed based on the underlying evidence.
  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2019 Carroll PR, Parsons JK
• Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry.
  European urology 2019 Jeong CW, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR
• Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and Research.
  JCO clinical cancer informatics 2019 Odisho AY, Bridge M, Webb M, Ameli N, Eapen RS, Stauf F, Cowan JE, Washington SL, Herlemann A, Carroll PR, Cooperberg MR
• Detection of clinically signifi cant prostate cancer with PIRADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions.
  International braz j urol : official journal of the Brazilian Society of Urology 2019 Westphalen AC, Fazel F, Nguyen H, Cabarrus M, Hanley-Knutson K, Shinohara K, Carroll PR
• Correlation of a Commercial Genomic Risk Classifier with Histological Patterns in Prostate Cancer.
  The Journal of urology 2019 Greenland NY, Zhang L, Cowan JE, Carroll PR, Stohr BA, Simko JP
• A Mobile Health Intervention for Prostate Biopsy Patients Reduces Appointment Cancellations: Cohort Study.
  Journal of medical Internet research 2019 Balakrishnan AS, Nguyen HG, Shinohara K, Au Yeung R, Carroll PR, Odisho AY
• Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.
  JAMA oncology 2019 Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, Nguyen HG, Reiter RE, Rettig MB, Okamoto S, Emmett L, Zacho HD, Ilhan H, Wetter A, Rischpler C, Schoder H, Burger IA, Gartmann J, Smith R,…
• Trends and Predictors of Adjuvant Therapy for Adverse Features Following Radical Prostatectomy: An Analysis From Cancer of the Prostate Strategic Urologic Research Endeavor.
  Urology 2019 Balakrishnan AS, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR
• The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement.
  European urology 2019 Cooperberg MR, Carroll PR, Dall'Era MA, Davies BJ, Davis JW, Eggener SE, Feng FY, Lin DW, Morgan TM, Morgans AK, Spratt DE, Taneja SS, Penson DF
• Single-Center Prospective Evaluation of 68Ga-PSMA-11 PET in Biochemical Recurrence of Prostate Cancer.
  AJR. American journal of roentgenology 2019 Lawhn-Heath C, Flavell RR, Behr SC, Yohannan T, Greene KL, Feng F, Carroll PR, Hope TA
• Editorial Comment.
  The Journal of urology 2019 Carroll P, Schmidt B
• Location of Recurrence by Gallium-68 PSMA-11 PET Scan in Prostate Cancer Patients Eligible for Salvage Radiotherapy.
  Urology 2019 Boreta L, Gadzinski AJ, Wu SY, Xu M, Greene K, Quanstrom K, Nguyen HG, Carroll PR, Hope TA, Feng FY
• Longitudinal Comparison of Patient-Level Outcomes and Costs Across Prostate Cancer Treatments With Urinary Problems.
  American journal of men's health 2019 Tang J, Zhong L, Paoli C, Paciorek A, Carroll P, Wilson L
• The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target.
  Journal of the National Cancer Institute 2019 Zhao SG, Lehrer J, Chang SL, Das R, Erho N, Liu Y, Sjöström M, Den RB, Freedland SJ, Klein EA, Karnes RJ, Schaeffer EM, Xu M, Speers C, Nguyen PL, Ross AE, Chan JM, Cooperberg MR, Carroll PR, …
• Editorial Comment.
  The Journal of urology 2019 Carroll P
• Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active Surveillance.
  The Journal of urology 2019 Kornberg Z, Cowan JE, Westphalen AC, Cooperberg MR, Chan JM, Zhao S, Shinohara K, Carroll PR
• Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS).
  Prostate cancer and prostatic diseases 2019 Newcomb LF, Zheng Y, Faino AV, Bianchi-Frias D, Cooperberg MR, Brown MD, Brooks JD, Dash A, Fabrizio MD, Gleave ME, Liss M, Morgan TM, Thompson IM, Wagner AA, Carroll PR, Nelson PS, Lin DW
• Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer.
  European urology oncology 2019 Xu MJ, Kornberg Z, Gadzinski AJ, Diao D, Cowan JE, Wu SY, Boreta L, Spratt DE, Behr SC, Nguyen HG, Cooperberg MR, Davicioni E, Roach M, Hope TA, Carroll PR, Feng FY
• Feasibility, Acceptability, and Behavioral Outcomes from a Technology-enhanced Behavioral Change Intervention (Prostate 8): A Pilot Randomized Controlled Trial in Men with Prostate Cancer.
  European urology 2019 Kenfield SA, Van Blarigan EL, Ameli N, Lavaki E, Cedars B, Paciorek AT, Monroy C, Tantum LK, Newton RU, Signorell C, Suh JH, Zhang L, Cooperberg MR, Carroll PR, Chan JM
• Continued 5α-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASS.
  The Journal of urology 2019 Kearns JT, Faino AV, Schenk JM, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner A, Zheng Y, Lin DW
• Impact of Staging 68Ga-PSMA-11 PET Scans on Radiation Treatment Plansin Patients With Prostate Cancer.
  Urology 2018 Wu SY, Boreta L, Shinohara K, Nguyen H, Gottschalk AR, Hsu IC, Roach M, Westphalen AC, Feng FY, Carroll PR, Chang AJ, Hope TA
• Metaanalysis of 68Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2018 Hope TA, Goodman JZ, Allen IE, Calais J, Fendler WP, Carroll PR
• Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2018 Behr SC, Aggarwal R, VanBrocklin HF, Flavell RR, Gao K, Small EJ, Blecha J, Jivan S, Hope TA, Simko JP, Kurhanewicz J, Noworolski SM, Korn NJ, De Los Santos R, Cooperberg MR, Carroll PR, Nguyen HG, …
• Effect of Increasing Levels of Web-Based Behavioral Support on Changes in Physical Activity, Diet, and Symptoms in Men With Prostate Cancer: Protocol for a Randomized Controlled Trial.
  JMIR research protocols 2018 Winters-Stone KM, Kenfield SA, Van Blarigan EL, Moe EL, Ramsdill JW, Daniel K, Macaire G, Paich K, Kessler ER, Kucuk O, Gillespie TW, Lyons KS, Beer TM, Broering JM, Carroll PR, Chan JM
• Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer.
  Radiology 2018 Hicks RM, Simko JP, Westphalen AC, Nguyen HG, Greene KL, Zhang L, Carroll PR, Hope TA
• A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy.
  European urology 2018 McKiernan J, Donovan MJ, Margolis E, Partin A, Carter B, Brown G, Torkler P, Noerholm M, Skog J, Shore N, Andriole G, Thompson I, Carroll P
• Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies.
  European urology oncology 2018 van der Kwast TH, Helleman J, Nieboer D, Bruinsma SM, Roobol MJ, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium, Trock B, Ehdaie B, Carroll P, Filson C,…
• Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy.
  European urology 2018 Leapman MS, Nguyen HG, Cowan JE, Xue L, Stohr B, Simko J, Cooperberg MR, Carroll PR
• Practice patterns of primary EBRT with and without ADT in prostate cancer treatment.
  Prostate cancer and prostatic diseases 2018 Schmidt B, Eapen RS, Cowan JE, Broering JM, Greene KL, Carroll PR, Cooperberg MR
• USPTF Prostate Cancer Screening Recommendations-A Step in the Right Direction.
  JAMA surgery 2018 Carroll PR
• Effect of Oscillation on Perineal Pressure in Cyclists: Implications for Micro-Trauma.
  Sexual medicine 2018 Sanford T, Gadzinski AJ, Gaither T, Osterberg EC, Murphy GP, Carroll PR, Breyer BN
• The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer.
  European urology 2018 Cooperberg MR, Erho N, Chan JM, Feng FY, Fishbane N, Zhao SG, Simko JP, Cowan JE, Lehrer J, Alshalalfa M, Kolisnik T, Chelliserry J, Margrave J, Aranes M, Plessis MD, Buerki C, Tenggara I, Davicioni E…
• Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer.
  European urology oncology 2018 Masic S, Cowan JE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR
• Optimal Radical Therapy for Localized Prostate Cancer: Recreation of the Self-Fulfilling Prophecy With Combination Brachytherapy?
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Spratt DE, Carroll PR
• Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer.
  European urology oncology 2018 Aggarwal R, Wei X, Kim W, Small EJ, Ryan CJ, Carroll P, Cooperberg M, Evans MJ, Hope T
• Development of a stress response therapy targeting aggressive prostate cancer.
  Science translational medicine 2018 Nguyen HG, Conn CS, Kye Y, Xue L, Forester CM, Cowan JE, Hsieh AC, Cunningham JT, Truillet C, Tameire F, Evans MJ, Evans CP, Yang JC, Hann B, Koumenis C, Walter P, Carroll PR, Ruggero D
• Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes.
  European urology 2018 Cooperberg MR, Brooks JD, Faino AV, Newcomb LF, Kearns JT, Carroll PR, Dash A, Etzioni R, Fabrizio MD, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Lin DW, Zheng Y
• Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study.
  European urology 2018 Kearns JT, Faino AV, Newcomb LF, Brooks JD, Carroll PR, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Zheng Y, Lin DW
• Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer.
  Oncotarget 2018 Sahoo D, Wei W, Auman H, Hurtado-Coll A, Carroll PR, Fazli L, Gleave ME, Lin DW, Nelson PS, Simko J, Thompson IM, Leach RJ, Troyer DA, True LD, McKenney JK, Feng Z, Brooks JD
• Scatter Artifact with Ga-68-PSMA-11 PET: Severity Reduced With Furosemide Diuresis and Improved Scatter Correction.
  Molecular imaging 2018 Lawhn-Heath C, Flavell RR, Korenchan DE, Deller T, Lake S, Carroll PR, Hope TA
• Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy.
  JAMA oncology 2017 Zhao SG, Chang SL, Erho N, Yu M, Lehrer J, Alshalalfa M, Speers C, Cooperberg MR, Kim W, Ryan CJ, Den RB, Freedland SJ, Posadas E, Sandler H, Klein EA, Black P, Seiler R, Tomlins SA, Chinnaiyan AM, …
• Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Spratt DE, Zhang J, Santiago-Jiménez M, Dess RT, Davis JW, Den RB, Dicker AP, Kane CJ, Pollack A, Stoyanova R, Abdollah F, Ross AE, Cole A, Uchio E, Randall JM, Nguyen H, Zhao SG, Mehra R, Glass AG, …
• Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts.
  Annals of internal medicine 2017 Inoue LYT, Lin DW, Newcomb LF, Leonardson AS, Ankerst D, Gulati R, Carter HB, Trock BJ, Carroll PR, Cooperberg MR, Cowan JE, Klotz LH, Mamedov A, Penson DF, Etzioni R
• Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™).
  The Prostate 2017 Tat D, Kenfield SA, Cowan JE, Broering JM, Carroll PR, Van Blarigan EL, Chan JM
• Cycling, and Male Sexual and Urinary Function: Results from a Large, Multinational, Cross-Sectional Study.
  The Journal of urology 2017 Awad MA, Gaither TW, Murphy GP, Chumnarnsongkhroh T, Metzler I, Sanford T, Sutcliffe S, Eisenberg ML, Carroll PR, Osterberg EC, Breyer BN
• Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa).
  PloS one 2017 Leapman MS, Westphalen AC, Ameli N, Lawrence HJ, Febbo PG, Cooperberg MR, Carroll PR
• Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers.
  The Prostate 2017 Zhou CK, Stanczyk FZ, Hafi M, Veneroso CC, Lynch B, Falk RT, Niwa S, Emanuel E, Gao YT, Hemstreet GP, Zolfghari L, Carroll PR, Manyak MJ, Sesterhenn IA, Levine PH, Hsing AW, Cook MB
• Characterization and stratification of prostate lesions based on comprehensive multiparametric MRI using detailed whole-mount histopathology as a reference standard.
  NMR in biomedicine 2017 Starobinets O, Simko JP, Kuchinsky K, Kornak J, Carroll PR, Greene KL, Kurhanewicz J, Noworolski SM
• Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy.
  The Journal of urology 2017 Garcia-Reyes K, Nguyen HG, Zagoria RJ, Shinohara K, Carroll PR, Behr SC, Westphalen AC
• Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy.
  The Journal of urology 2017 Nguyen HG, Welty C, Lindquist K, Ngo V, Gilbert E, Bengtsson H, Magi-Galluzzi C, Jean-Gilles J, Yao J, Cooperberg M, Messing E, Klein EA, Carroll PR, Paris PL
• Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer.
  EJNMMI research 2017 Lake ST, Greene KL, Westphalen AC, Behr SC, Zagoria R, Small EJ, Carroll PR, Hope TA
• The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy.
  Cancer 2017 Welty CJ, Sanford TH, Wright JL, Carroll PR, Cooperberg MR, Meng MV, Porten SP
• Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer.
  Radiologia brasileira 2017 Leapman MS, Wang ZJ, Behr SC, Kurhanewicz J, Zagoria RJ, Carroll PR, Westphalen AC
• Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2017 Cook MB, Stanczyk FZ, Wood SN, Pfeiffer RM, Hafi M, Veneroso CC, Lynch B, Falk RT, Zhou CK, Niwa S, Emanuel E, Gao YT, Hemstreet GP, Zolfghari L, Carroll PR, Manyak MJ, Sesterhann IA, Levine PH, Hsing…
• Outcomes of men on active surveillance for low-risk prostate cancer at a safety-net hospital.
  Urologic oncology 2017 Osterberg EC, Palmer NRA, Harris CR, Murphy GP, Blaschko SD, Chu C, Allen IE, Cooperberg MR, Carroll PR, Breyer BN
• Impact of 68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017 Hope TA, Aggarwal R, Chee B, Tao D, Greene KL, Cooperberg MR, Feng F, Chang A, Ryan CJ, Small EJ, Carroll PR
• Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy.
  European urology 2017 Herlemann A, Cowan JE, Carroll PR, Cooperberg MR
• AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer.
  The Journal of urology 2017 Fulgham PF, Rukstalis DB, Turkbey IB, Rubenstein JN, Taneja S, Carroll PR, Pinto PA, Bjurlin MA, Eggener S
• Management of intermediate-risk prostate cancer with active surveillance: never or sometimes?
  Current opinion in urology 2017 Masic S, Washington SL, Carroll PR
• The Fitbit One Physical Activity Tracker in Men With Prostate Cancer: Validation Study.
  JMIR cancer 2017 Van Blarigan EL, Kenfield SA, Tantum L, Cadmus-Bertram LA, Carroll PR, Chan JM
• Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting.
  Prostate international 2017 Kim CS, Lee JY, Chung BH, Kim WJ, Fai NC, Hakim L, Umbas R, Ong TA, Lim J, Letran JL, Chiong E, Wu TL, Lojanapiwat B, Türkeri L, Murphy DG, Gardiner RA, Moretti K, Cooperberg M, Carroll P, Mun SK, …
• Active Surveillance in Younger Men With Prostate Cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2017 Leapman MS, Cowan JE, Nguyen HG, Shinohara KK, Perez N, Cooperberg MR, Catalona WJ, Carroll PR
• Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments.
  The Journal of urology 2017 Vertosick EA, Vickers AJ, Cowan JE, Broering JM, Carroll PR, Cooperberg MR
• Low-risk Prostate Cancer: Identification, Management, and Outcomes.
  European urology 2017 Moschini M, Carroll PR, Eggener SE, Epstein JI, Graefen M, Montironi R, Parker C
• Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure.
  Nature reviews. Urology 2017 Bruinsma SM, Roobol MJ, Carroll PR, Klotz L, Pickles T, Moore CM, Gnanapragasam VJ, Villers A, Rannikko A, Valdagni R, Frydenberg M, Kakehi Y, Filson CP, Bangma CH, Movember Foundation's Global Action…
• A randomised clinical study to determine the effect of a toothpaste containing enzymes and proteins on plaque oral microbiome ecology.
  Scientific reports 2017 Adams SE, Arnold D, Murphy B, Carroll P, Green AK, Smith AM, Marsh PD, Chen T, Marriott RE, Brading MG
• Medicine information exchange networks among healthcare professionals and prescribing in geriatric medicine wards.
  British journal of clinical pharmacology 2017 Chan B, Reeve E, Matthews S, Carroll PR, Long JC, Held F, Latt M, Naganathan V, Caplan GA, Hilmer SN
• Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes.
  European urology 2016 Leapman MS, Cowan JE, Simko J, Roberge G, Stohr BA, Carroll PR, Cooperberg MR
• Tissue Sources for Accurate Measurement of Germline DNA Genotypes in Prostate Cancer Patients Treated With Radical Prostatectomy.
  The Prostate 2016 Emami NC, Leong L, Wan E, Van Blarigan EL, Cooperberg MR, Tenggara I, Carroll PR, Chan JM, Witte JS, Simko JP
• Evaluating the Four Kallikrein Panel of the 4Kscore for Prediction of High-grade Prostate Cancer in Men in the Canary Prostate Active Surveillance Study.
  European urology 2016 Lin DW, Newcomb LF, Brown MD, Sjoberg DD, Dong Y, Brooks JD, Carroll PR, Cooperberg M, Dash A, Ellis WJ, Fabrizio M, Gleave ME, Morgan TM, Nelson PS, Thompson IM, Wagner AA, Zheng Y, Canary Prostate …
• MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study.
  PloS one 2016 Eminaga O, Wei W, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave ME, Lin DW, Nelson PS, Thompson IM, True LD, McKenney JK, Feng Z, Fazli L, Brooks JD
• Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort.
  The American journal of surgical pathology 2016 McKenney JK, Wei W, Hawley S, Auman H, Newcomb LF, Boyer HD, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Tretiakova MS, Vakar-Lopez F, Carroll PR, Cooperberg MR, Gleave ME, Lance RS, Lin DW, Nelson …
• Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study.
  The Journal of urology 2016 Macleod LC, Ellis WJ, Newcomb LF, Zheng Y, Brooks JD, Carroll PR, Gleave ME, Lance RS, Nelson PS, Thompson IM, Wagner AA, Wei JT, Lin DW
• Risk Stratification of Newly Diagnosed Prostate Cancer with Genomic Platforms.
  Urology practice 2016 Leapman MS, Carroll PR
• Variation and Predictors of Surgical Case Costs among Urologists.
  Urology practice 2016 Hampson LA, Odisho AY, Meng MV, Carroll PR
• What is the best way not to treat prostate cancer?
  Urologic oncology 2016 Leapman MS, Carroll PR
• Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis.
  The Lancet. Oncology 2016 Zhao SG, Chang SL, Spratt DE, Erho N, Yu M, Ashab HA, Alshalalfa M, Speers C, Tomlins SA, Davicioni E, Dicker AP, Carroll PR, Cooperberg MR, Freedland SJ, Karnes RJ, Ross AE, Schaeffer EM, Den RB, …
• Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes.
  PloS one 2016 Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll PR
• Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task Force.
  European urology 2016 Villa S, Kendel F, Venderbos L, Rancati T, Bangma C, Carroll P, Denis L, Klotz L, Korfage IJ, Lane AJ, Magnani T, Mastris K, Rannikko A, Roobol M, Trock B, Van den Bergh R, Van Poppel H, Valdagni R, …
• Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer.
  Cancer immunology research 2016 Wei XX, Chan S, Kwek S, Lewis J, Dao V, Zhang L, Cooperberg MR, Ryan CJ, Lin AM, Friedlander TW, Rini B, Kane C, Simko JP, Carroll PR, Small EJ, Fong L
• A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical Prostatectomy.
  The Journal of urology 2016 Nguyen HG, Punnen S, Cowan JE, Leapman M, Cary C, Welty C, Weinberg V, Cooperberg MR, Meng MV, Greene KL, Garcia M, Carroll PR
• 68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience.
  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2016 Hope TA, Truillet C, Ehman EC, Afshar-Oromieh A, Aggarwal R, Ryan CJ, Carroll PR, Small EJ, Evans MJ
• A complicated case of splenic injury after colonoscopy - a video vignette.
  Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2016 Kelly B, Heneghan H, Carroll P, McDermott E
• Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance.
  European urology 2016 Tran GN, Leapman MS, Nguyen HG, Cowan JE, Shinohara K, Westphalen AC, Carroll PR
• 18F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons.
  Radiology 2016 Choi JY, Yang J, Noworolski SM, Behr S, Chang AJ, Simko JP, Nguyen HG, Carroll PR, Kurhanewicz J, Seo Y
• Validity of the Cancer of the Prostate Risk Assessment Score Derived From Targeted Biopsy: Modeling Evidence From Ultrasound Lesion-Directed Biopsy.
  Clinical genitourinary cancer 2016 Leapman MS, Ameli N, Shinohara K, Nguyen HG, Meng MV, Cooperberg MR, Carroll PR
• A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment.
  Prostate cancer and prostatic diseases 2016 Liss MA, Schenk JM, Faino AV, Newcomb LF, Boyer H, Brooks JD, Carroll PR, Dash A, Fabrizio MD, Gleave ME, Nelson PS, Neuhouser ML, Wei JT, Zheng Y, Wright JL, Lin DW, Thompson IM
• An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care.
  Urology 2016 Crawford ED, Rosenberg MT, Partin AW, Cooperberg MR, Maccini M, Loeb S, Pettaway CA, Shore ND, Arangua P, Hoenemeyer J, Leveridge M, Leapman M, Pinto P, Thompson IM, Carroll P, Eastham J, Gomella L, …
• A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.
  JAMA oncology 2016 McKiernan J, Donovan MJ, O'Neill V, Bentink S, Noerholm M, Belzer S, Skog J, Kattan MW, Partin A, Andriole G, Brown G, Wei JT, Thompson IM, Carroll P
• Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.
  The Journal of urology 2016 Leapman MS, Freedland SJ, Aronson WJ, Kane CJ, Terris MK, Walker K, Amling CL, Carroll PR, Cooperberg MR
• Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force.
  European urology 2016 Moore CM, Giganti F, Albertsen P, Allen C, Bangma C, Briganti A, Carroll P, Haider M, Kasivisvanathan V, Kirkham A, Klotz L, Ouzzane A, Padhani AR, Panebianco V, Pinto P, Puech P, Rannikko A, Renard-…
• Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort.
  The Prostate 2016 Brooks JD, Wei W, Pollack JR, West RB, Shin JH, Sunwoo JB, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave ME, Lin DW, Nelson PS, Thompson IM, True LD, McKenney …
• PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer.
  European urology focus 2016 Lotan TL, Wei W, Morais CL, Hawley ST, Fazli L, Hurtado-Coll A, Troyer D, McKenney JK, Simko J, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, Brooks JD
• Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Lotan TL, Wei W, Ludkovski O, Morais CL, Guedes LB, Jamaspishvili T, Lopez K, Hawley ST, Feng Z, Fazli L, Hurtado-Coll A, McKenney JK, Simko J, Carroll PR, Gleave M, Lin DW, Nelson PS, Thompson IM, …
• Immediate androgen deprivation: for all or for some?
  The Lancet. Oncology 2016 Leapman MS, Carroll PR
• Quantified Clinical Risk Change as an End Point During Prostate Cancer Active Surveillance.
  European urology 2016 Leapman MS, Ameli N, Cooperberg MR, Chu C, Hussein A, Shinohara K, Carroll PR
• Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies.
  Prostate cancer and prostatic diseases 2016 Tretiakova MS, Wei W, Boyer HD, Newcomb LF, Hawley S, Auman H, Vakar-Lopez F, McKenney JK, Fazli L, Simko J, Troyer DA, Hurtado-Coll A, Thompson IM, Carroll PR, Ellis WJ, Gleave ME, Nelson PS, Lin DW,…
• NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.
  Journal of the National Comprehensive Cancer Network : JNCCN 2016 Carroll PR, Parsons JK, Andriole G, Bahnson RR, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP, Kawachi MH, Kim S, Lange PH, Loughlin KR, Lowrance W, …
• Serial Anatomical Prostate Ultrasound during Prostate Cancer Active Surveillance.
  The Journal of urology 2016 Eltemamy MM, Leapman MS, Cowan JE, Westphalen A, Shinohara K, Carroll PR
• Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery.
  American journal of clinical oncology 2016 Crehange G, Izaguirre A, Weinberg V, Hsu CC, Gottschalk AR, Hsu IC, Shinohara K, Carroll P, Roach M
• Asia prostate cancer study (A-CaP Study) launch symposium.
  Prostate international 2016 Akaza H, Hirao Y, Kim CS, Oya M, Ozono S, Ye D, Cooperberg M, Hinotsu S, Lee JY, Zhu G, Namiki M, Horie S, Chung BH, Chen CH, Fai NC, Hakim L, Chiong E, Letran J, Umbas R, Suzuki K, Nishimura K, Ong …
• Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens.
  The Journal of molecular diagnostics : JMD 2016 Knudsen BS, Kim HL, Erho N, Shin H, Alshalalfa M, Lam LLC, Tenggara I, Chadwich K, Van Der Kwast T, Fleshner N, Davicioni E, Carroll PR, Cooperberg MR, Chan JM, Simko JP
• Active surveillance for prostate cancer: a narrative review of clinical guidelines.
  Nature reviews. Urology 2016 Bruinsma SM, Bangma CH, Carroll PR, Leapman MS, Rannikko A, Petrides N, Weerakoon M, Bokhorst LP, Roobol MJ, Movember GAP3 consortium
• Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score.
  Urology 2015 Brand TC, Zhang N, Crager MR, Maddala T, Dee A, Sesterhenn IA, Simko JP, Cooperberg MR, Srivastava S, Rosner IL, Chan JM, Febbo PG, Carroll PR, Cullen J, Lawrence HJ
• NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015.
  Journal of the National Comprehensive Cancer Network : JNCCN 2015 Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP, Kawachi MH, Lange PH, Loughlin KR, Lowrance W…
• Who and when should we screen for prostate cancer? Interviews with key opinion leaders.
  BMC medicine 2015 Carlsson S, Leapman M, Carroll P, Schröder F, Albertsen PC, Ilic D, Barry M, Frosch DL, Vickers A
• Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer.
  The Prostate 2015 Nordström T, Van Blarigan EL, Ngo V, Roy R, Weinberg V, Song X, Simko J, Carroll PR, Chan JM, Paris PL
• Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors.
  Science signaling 2015 Hsieh AC, Nguyen HG, Wen L, Edlind MP, Carroll PR, Kim W, Ruggero D
• Treatment Trends for Prostate Cancer--Reply.
  JAMA 2015 Cooperberg MR, Carroll PR
• New Genetic Markers for Prostate Cancer.
  The Urologic clinics of North America 2015 Leapman MS, Carroll PR
• Bicycle Trauma Injuries and Hospital Admissions in the United States, 1998-2013.
  JAMA 2015 Sanford T, McCulloch CE, Callcut RA, Carroll PR, Breyer BN
• Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.
  The Journal of urology 2015 Newcomb LF, Thompson IM, Boyer HD, Brooks JD, Carroll PR, Cooperberg MR, Dash A, Ellis WJ, Fazli L, Feng Z, Gleave ME, Kunju P, Lance RS, McKenney JK, Meng MV, Nicolas MM, Sanda MG, Simko J, So A, …
• Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients.
  PloS one 2015 Brooks JD, Wei W, Hawley S, Auman H, Newcomb L, Boyer H, Fazli L, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Feng Z, McKenney JK
• Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.
  JAMA 2015 Cooperberg MR, Carroll PR
• Immediate versus delayed radical prostatectomy: updated outcomes following active surveillance of prostate cancer.
  European urology 2015 Filippou P, Welty CJ, Cowan JE, Perez N, Shinohara K, Carroll PR
• What is the Optimal Way to Select Candidates for Active Surveillance of Prostate Cancer?
  The Journal of urology 2015 Dall'Era M, Carroll P
• A comparison of medical and pharmacy students' knowledge and skills of pharmacology and pharmacotherapy.
  British journal of clinical pharmacology 2015 Hilmer SN, Seale JP, Carroll PR
• Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?
  BJU international 2015 Hsu CC, Paciorek AT, Cooperberg MR, Roach M, Hsu IC, Carroll PR
• Patterns of Local Failure following Radiation Therapy for Prostate Cancer.
  The Journal of urology 2015 Jalloh M, Leapman MS, Cowan JE, Shinohara K, Greene KL, Roach M, Chang AJ, Chan JM, Simko JP, Carroll PR
• Trans-Pacific variation in outcomes for men treated with primary androgen-deprivation therapy (ADT) for prostate cancer.
  BJU international 2015 Cooperberg MR, Hinotsu S, Namiki M, Carroll PR, Akaza H
• A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer.
  The Prostate 2015 Troyer DA, Jamaspishvili T, Wei W, Feng Z, Good J, Hawley S, Fazli L, McKenney JK, Simko J, Hurtado-Coll A, Carroll PR, Gleave M, Lance R, Lin DW, Nelson PS, Thompson IM, True LD, Brooks JD, Squire JA
• Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk Calculator.
  European urology 2015 Ankerst DP, Xia J, Thompson IM, Hoefler J, Newcomb LF, Brooks JD, Carroll PR, Ellis WJ, Gleave ME, Lance RS, Nelson PS, Wagner AA, Wei JT, Etzioni R, Lin DW
• Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study.
  European journal of cancer (Oxford, England : 1990) 2015 Garcia-Albeniz X, Chan JM, Paciorek A, Logan RW, Kenfield SA, Cooperberg MR, Carroll PR, Hernán MA
• Impact of age on quality-of-life outcomes after treatment for localized prostate cancer.
  European urology 2015 Hampson LA, Cowan JE, Zhao S, Carroll PR, Cooperberg MR
• Current Use of Imaging after Primary Treatment of Prostate Cancer.
  The Journal of urology 2015 Hussein AA, Punnen S, Zhao S, Cowan JE, Leapman M, Tran TC, Washington SL, Truesdale MD, Carroll PR, Cooperberg MR
• Mycobacterium tuberculosis H37Rv has a single nucleotide polymorphism in PhoR which affects cell wall hydrophobicity and gene expression.
  Microbiology (Reading, England) 2015 Schreuder LJ, Carroll P, Muwanguzi-Karugaba J, Kokoczka R, Brown AC, Parish T
• Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes.
  The Journal of urology 2015 Hussein AA, Welty CJ, Ameli N, Cowan JE, Leapman M, Porten SP, Shinohara K, Carroll PR
• Active surveillance for low-risk prostate cancer: developments to date.
  European urology 2014 Bangma CH, Valdagni R, Carroll PR, van Poppel H, Klotz L, Hugosson J
• Sustainable Measurement of Response Shift in Prostate Cancer Patients: Adjusting Health Related Quality of Life with the Then-Test.
  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2014 Ten Ham RM, Wilson LS, Broering JM, Cooperberg MR, Carroll P
• Overdetection of recurrence after radical prostatectomy: estimates based on patient and tumor characteristics.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Xia J, Trock BJ, Gulati R, Mallinger L, Cooperberg MR, Carroll PR, Carter HB, Etzioni R
• Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
  The Prostate 2014 Gerstenberger JP, Bauer SR, Van Blarigan EL, Sosa E, Song X, Witte JS, Carroll PR, Chan JM
• Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer.
  The Journal of urology 2014 Welty CJ, Cowan JE, Nguyen H, Shinohara K, Perez N, Greene KL, Chan JM, Meng MV, Simko JP, Cooperberg MR, Carroll PR
• Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer.
  Journal of the National Cancer Institute 2014 Fong L, Carroll P, Weinberg V, Chan S, Lewis J, Corman J, Amling CL, Stephenson RA, Simko J, Sheikh NA, Sims RB, Frohlich MW, Small EJ
• Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
  European urology 2014 Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR
• Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines.
  Journal of the National Comprehensive Cancer Network : JNCCN 2014 Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, …
• Reply to Yuri Tolkach, Markus Kuczyk, Florian Imkamp's letter to the editor re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur urol 2014;66:550-60.
  European urology 2014 Klein EA, Cooperberg MR, Carroll PR
• Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer management.
  Prostate international 2014 Akaza H, Kim CS, Carroll P, Choi IY, Chung BH, Cooperberg MR, Hirao Y, Hinotsu S, Horie S, Lee JY, Namiki M, Ng CF, Onozawa M, Ozono S, Ueno S, Umbas R, Ye D, Zhu G
• miR-19, miR-345, miR-519c-5p serum levels predict adverse pathology in prostate cancer patients eligible for active surveillance.
  PloS one 2014 Wang SY, Shiboski S, Belair CD, Cooperberg MR, Simko JP, Stoppler H, Cowan J, Carroll PR, Blelloch R
• A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
  European urology 2014 Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, …
• Updated trends in imaging use in men diagnosed with prostate cancer.
  Prostate cancer and prostatic diseases 2014 Porten SP, Smith A, Odisho AY, Litwin MS, Saigal CS, Carroll PR, Cooperberg MR, Urologic Disease of America Project
• Evolution and immediate future of US screening guidelines.
  The Urologic clinics of North America 2014 Greene KL, Punnen S, Carroll PR
• Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancer.
  Current opinion in urology 2014 Welty CJ, Cooperberg MR, Carroll PR
• Point/Counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences?
  Journal of the National Comprehensive Cancer Network : JNCCN 2014 Carroll PR, Vickers AJ
• Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
  European urology 2014 Jalloh M, Myers F, Cowan JE, Carroll PR, Cooperberg MR
• Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop.
  Urology 2014 Jarow JP, Thompson IM, Kluetz PG, Baxley J, Sridhara R, Scardino P, Carroll P, Albertsen P, Carter HB, Brawley O, Sartor O, Sandler H, Kiefert JJ, Morton RA
• A risk-adjusted definition of biochemical recurrence after radical prostatectomy.
  Prostate cancer and prostatic diseases 2014 Morgan TM, Meng MV, Cooperberg MR, Cowan JE, Weinberg V, Carroll PR, Lin DW
• Endoscopic gold fiducial marker placement into the bladder wall to optimize radiotherapy targeting for bladder-preserving management of muscle-invasive bladder cancer: feasibility and initial outcomes.
  PloS one 2014 Garcia MM, Gottschalk AR, Brajtbord J, Konety BR, Meng MV, Roach M, Carroll PR
• A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer.
  Urology 2014 Vickers AJ, Thompson IM, Klein E, Carroll PR, Scardino PT
• Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study.
  Drugs & aging 2014 Bennett A, Gnjidic D, Gillett M, Carroll P, Matthews S, Johnell K, Fastbom J, Hilmer S
• The ongoing need for improved risk stratification and monitoring for those on active surveillance for early stage prostate cancer.
  European urology 2014 Welty CJ, Carroll PR
• Age and baseline quality of life at radical prostatectomy--who has the most to lose?
  The Journal of urology 2014 Brajtbord JS, Punnen S, Cowan JE, Welty CJ, Carroll PR
• Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer.
  BJU international 2014 Wang SY, Cowan JE, Cary KC, Chan JM, Carroll PR, Cooperberg MR
• The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration.
  European journal of clinical pharmacology 2014 Johnston C, Hilmer SN, McLachlan AJ, Matthews ST, Carroll PR, Kirkpatrick CM
• Physical activity and prostate gene expression in men with low-risk prostate cancer.
  Cancer causes & control : CCC 2014 Magbanua MJ, Richman EL, Sosa EV, Jones LW, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM
• Role of endorectal MR imaging and MR spectroscopic imaging in defining treatable intraprostatic tumor foci in prostate cancer: quantitative analysis of imaging contour compared to whole-mount histopathology.
  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2014 Anwar M, Westphalen AC, Jung AJ, Noworolski SM, Simko JP, Kurhanewicz J, Roach M, Carroll PR, Coakley FV
• Overdiagnosis and overtreatment of prostate cancer.
  European urology 2014 Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, Carroll P, Etzioni R
• The argument for palliative care in prostate cancer.
  Translational andrology and urology 2013 Sanford MT, Greene KL, Carroll PR
• Serial prostate biopsy and risk of lower urinary tract symptoms: results from a large, single-institution active surveillance cohort.
  Urology 2013 Glass AS, Hilton JF, Cowan JE, Washington SL, Carroll PR
• Clinical utility of endorectal MRI-guided prostate biopsy: preliminary experience.
  Journal of magnetic resonance imaging : JMRI 2013 Jung AJ, Westphalen AC, Kurhanewicz J, Wang ZJ, Carroll PR, Simko JP, Coakley FV
• Impact of androgen deprivation therapy on mental and emotional well-being in men with prostate cancer: analysis from the CaPSURE™ registry.
  The Journal of urology 2013 Cary KC, Singla N, Cowan JE, Carroll PR, Cooperberg MR
• Temporal trends and predictors of salvage cancer treatment after failure following radical prostatectomy or radiation therapy: an analysis from the CaPSURE registry.
  Cancer 2013 Cary KC, Paciorek A, Fuldeore MJ, Carroll PR, Cooperberg MR
• Semiautomatic registration of digital histopathology images to in vivo MR images in molded and unmolded prostates.
  Journal of magnetic resonance imaging : JMRI 2013 Starobinets O, Guo R, Simko JP, Kuchinsky K, Kurhanewicz J, Carroll PR, Greene KL, Noworolski SM
• Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™.
  The Journal of urology 2013 Tomaszewski JJ, Richman EL, Sadetsky N, O'Keefe DS, Carroll PR, Davies BJ, Chan JM
• Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study.
  The Lancet. Oncology 2013 Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, Marlin R, Frenda SJ, Magbanua MJM, Daubenmier J, Estay I, Hills NK, Chainani-Wu N, Carroll PR, Blackburn EH
• Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies.
  European urology 2013 Cary KC, Cowan JE, Sanford M, Shinohara K, Perez N, Chan JM, Meng MV, Carroll PR
• Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence.
  The Prostate 2013 Bauer SR, Richman EL, Sosa E, Weinberg V, Song X, Witte JS, Carroll PR, Chan JM
• Autologous retro-pubic urethral sling: a novel, quick, intra-operative technique to improve continence after robotic-assisted radical prostatectomy.
  Journal of robotic surgery 2013 Punnen S, Clint Cary K, Glass AS, Cowan JE, Carroll PR
• Early salvage radiotherapy following radical prostatectomy.
  European urology 2013 Pfister D, Bolla M, Briganti A, Carroll P, Cozzarini C, Joniau S, van Poppel H, Roach M, Stephenson A, Wiegel T, Zelefsky MJ
• Measurement equivalence using a mixed-mode approach to administer health-related quality of life instruments.
  Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2013 Broering JM, Paciorek A, Carroll PR, Wilson LS, Litwin MS, Miaskowski C
• Reply to A. Azad et al.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Cooperberg MR, Cowan JE, Carroll PR
• Editorial comment.
  The Journal of urology 2013 Cary KC, Carroll PR
• A longitudinal study of anxiety, depression and distress as predictors of sexual and urinary quality of life in men with prostate cancer.
  BJU international 2013 Punnen S, Cowan JE, Dunn LB, Shumay DM, Carroll PR, Cooperberg MR
• Sixth joint meeting of J-CaP and CaPSURE--a multinational perspective on prostate cancer management and patient outcomes.
  Japanese journal of clinical oncology 2013 Akaza H, Hinotsu S, Cooperberg MR, Chung BH, Youl Lee J, Umbas R, Tsukamoto T, Namiki M, Carroll P
• Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era.
  Urology 2013 Glass AS, Cowan JE, Fuldeore MJ, Cooperberg MR, Carroll PR, Kenfield SA, Greene KL
• Endorectal MRI and MR spectroscopic imaging of prostate cancer: developing selection criteria for MR-guided focal therapy.
  Journal of magnetic resonance imaging : JMRI 2013 Chang ST, Westphalen AC, Jha P, Jung AJ, Carroll PR, Kurhanewicz J, Coakley FV
• Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy.
  European urology 2013 Punnen S, Freedland SJ, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Carroll PR, Cooperberg MR
• Benign prostate glandular tissue at radical prostatectomy surgical margins.
  Urology 2013 Odisho AY, Washington SL, Meng MV, Cowan JE, Simko JP, Carroll PR
• Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Lin DW, Newcomb LF, Brown EC, Brooks JD, Carroll PR, Feng Z, Gleave ME, Lance RS, Sanda MG, Thompson IM, Wei JT, Nelson PS, Canary Prostate Active Surveillance Study Investigators
• How does robot-assisted radical prostatectomy (RARP) compare with open surgery in men with high-risk prostate cancer?
  BJU international 2013 Punnen S, Meng MV, Cooperberg MR, Greene KL, Cowan JE, Carroll PR
• Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Cooperberg MR, Simko JP, Cowan JE, Reid JE, Djalilvand A, Bhatnagar S, Gutin A, Lanchbury JS, Swanson GP, Stone S, Carroll PR
• Men with low preoperative sexual function may benefit from nerve sparing radical prostatectomy.
  The Journal of urology 2013 Harris CR, Punnen S, Carroll PR
• Active surveillance: does serial prostate biopsy increase histological inflammation?
  Prostate cancer and prostatic diseases 2013 Glass AS, Porten SP, Bonham M, Tran TC, Cowan JE, Punnen S, Chan JM, Carroll PR
• Focal therapy: a new active surveillance tool?
  Oncology (Williston Park, N.Y.) 2013 Glass AS, Carroll PR
• A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.
  Advances in anatomic pathology 2013 Hawley S, Fazli L, McKenney JK, Simko J, Troyer D, Nicolas M, Newcomb LF, Cowan JE, Crouch L, Ferrari M, Hernandez J, Hurtado-Coll A, Kuchinsky K, Liew J, Mendez-Meza R, Smith E, Tenggara I, Zhang X, …
• Prostate specific antigen best practice statement: 2009 update.
  The Journal of urology 2013 Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P, American Urological Association
• Role of active surveillance in the management of localized prostate cancer.
  Journal of the National Cancer Institute. Monographs 2012 Glass AS, Cooperberg MR, Meng MV, Carroll PR
• Salvage therapies after radiation therapy.
  Urologic oncology 2012 Eastham JA, Carroll P, Pisters L, Nguyen PT, Touijer K
• Prostate cancer mortality following active surveillance versus immediate radical prostatectomy.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Xia J, Trock BJ, Cooperberg MR, Gulati R, Zeliadt SB, Gore JL, Lin DW, Carroll PR, Carter HB, Etzioni R
• Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
  BJU international 2012 Resnick MJ, Guzzo TJ, Cowan JE, Knight SJ, Carroll PR, Penson DF
• Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Choe KS, Cowan JE, Chan JM, Carroll PR, D'Amico AV, Liauw SL
• Reply to Jai Prakash, Apul Goel and Manish Garg's Letter to the Editor re: Anobel Y. Odisho, Anna B. Berry, Ardalan E. Ahmad, Matthew R. Cooperberg, Peter R. Carroll, Badrinath R. Konety. Reflex ImmunoCyt Testing for the Diagnosis of Bladder Cancer in Patients with Atypical Urine Cytology. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.04.019.
  European urology 2012 Odisho AY, Berry AB, Ahmad AE, Cooperberg MR, Carroll PR, Konety BR
• Gender differences in academic productivity and academic career choice among urology residents.
  The Journal of urology 2012 Yang G, Villalta JD, Weiss DA, Carroll PR, Breyer BN
• The impact of serial prostate biopsies on sexual function in men on active surveillance for prostate cancer.
  The Journal of urology 2012 Hilton JF, Blaschko SD, Whitson JM, Cowan JE, Carroll PR
• Active surveillance for low-risk prostate cancer.
  Critical reviews in oncology/hematology 2012 Bangma CH, Bul M, van der Kwast TH, Pickles T, Korfage IJ, Hoeks CM, Steyerberg EW, Jenster G, Kattan MW, Bellardita L, Carroll PR, Denis LJ, Parker C, Roobol MJ, Emberton M, Klotz LH, Rannikko A, …
• The effect of behavioural risk factors on osteoporosis in Irish women.
  Irish journal of medical science 2012 Cummins NM, Jakeman PM, Sestak I, Murphy N, Carroll P
• Early detection of prostate cancer: more information, more clarity.
  European urology 2012 Glass AS, Cooperberg MR, Carroll PR
• Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram.
  Prostate cancer and prostatic diseases 2012 Kutikov A, Cooperberg MR, Paciorek AT, Uzzo RG, Carroll PR, Boorjian SA
• Local staging of prostate cancer: comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound.
  Clinical imaging 2012 Jung AJ, Coakley FV, Shinohara K, Carroll PR, Kurhanewicz J, Cowan JE, Westphalen AC
• Active surveillance for prostate cancer: a systematic review of the literature.
  European urology 2012 Dall'Era MA, Albertsen PC, Bangma C, Carroll PR, Carter HB, Cooperberg MR, Freedland SJ, Klotz LH, Parker C, Soloway MS
• Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel.
  European urology 2012 Montorsi F, Wilson TG, Rosen RC, Ahlering TE, Artibani W, Carroll PR, Costello A, Eastham JA, Ficarra V, Guazzoni G, Menon M, Novara G, Patel VR, Stolzenburg JU, Van der Poel H, Van Poppel H, Mottrie …
• The quantitative Gleason score improves prostate cancer risk assessment.
  Cancer 2012 Reese AC, Cowan JE, Brajtbord JS, Harris CR, Carroll PR, Cooperberg MR
• Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy.
  European urology 2012 Novara G, Ficarra V, Mocellin S, Ahlering TE, Carroll PR, Graefen M, Guazzoni G, Menon M, Patel VR, Shariat SF, Tewari AK, Van Poppel H, Zattoni F, Montorsi F, Mottrie A, Rosen RC, Wilson TG
• Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy.
  European urology 2012 Ficarra V, Novara G, Rosen RC, Artibani W, Carroll PR, Costello A, Menon M, Montorsi F, Patel VR, Stolzenburg JU, Van der Poel H, Wilson TG, Zattoni F, Mottrie A
• Regional cell proliferation in microdissected human prostate specimens after heavy water labeling in vivo: correlation with prostate epithelial cells isolated from seminal fluid.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Hayes GM, Simko J, Holochwost D, Kuchinsky K, Busch R, Misell L, Murphy EJ, Carroll P, Chan J, Shinohara K, Hellerstein MK
• Characteristics of older and younger patients with suspected paracetamol toxicity.
  Australasian journal on ageing 2012 Kane A, Mitchell SJ, Carroll PR, Matthews S, Hilmer SN
• Reflex ImmunoCyt testing for the diagnosis of bladder cancer in patients with atypical urine cytology.
  European urology 2012 Odisho AY, Berry AB, Ahmad AE, Cooperberg MR, Carroll PR, Konety BR
• Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109.
  Urology 2012 Berglund RK, Tangen CM, Powell IJ, Lowe BA, Haas GP, Carroll PR, Canby-Hagino ED, deVere White R, Hemstreet GP, Crawford ED, Thompson IM, Klein EA
• Proton beam therapy and treatment for localized prostate cancer: if you build it, they will come.
  Archives of internal medicine 2012 Aaronson DS, Odisho AY, Hills N, Cress R, Carroll PR, Dudley RA, Cooperberg MR
• Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study.
  International journal of radiation oncology, biology, physics 2012 Arrayeh E, Westphalen AC, Kurhanewicz J, Roach M, Jung AJ, Carroll PR, Coakley FV
• Fifth Joint Meeting of J-CaP and CaPSURE: advancing the global understanding of prostate cancer and its management.
  Japanese journal of clinical oncology 2012 Akaza H, Carroll P, Cooperberg MR, Hinotsu S
• Outcomes for radical prostatectomy: is it the singer, the song, or both?
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Cooperberg MR, Odisho AY, Carroll PR
• The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing.
  Urologic oncology 2012 Messing EM, Albertsen P, Andriole GL, Carroll PR, Klein EA
• Endorectal MRI of prostate cancer: incremental prognostic importance of gross locally advanced disease.
  AJR. American journal of roentgenology 2011 Muglia VF, Westphalen AC, Wang ZJ, Kurhanewicz J, Carroll PR, Coakley FV
• PSA screening: determinants of primary-care physician practice patterns.
  Prostate cancer and prostatic diseases 2011 Tasian GE, Cooperberg MR, Potter MB, Cowan JE, Greene KL, Carroll PR, Chan JM
• Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer.
  BJU international 2011 Washington SL, Bonham M, Whitson JM, Cowan JE, Carroll PR
• Poor agreement of prostate specific antigen doubling times calculated using ultrasensitive versus standard prostate specific antigen values: important impact on risk assessment.
  The Journal of urology 2011 Reese AC, Fradet V, Whitson JM, Davis CB, Carroll PR
• Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores?
  BJU international 2011 Punnen S, Cooperberg MR, Sadetsky N, Carroll PR
• Changes in cancer volume in serial biopsies of men on active surveillance for early stage prostate cancer.
  The Journal of urology 2011 Porten SP, Whitson JM, Cowan JE, Perez N, Shinohara K, Carroll PR
• Prediction of erectile function following treatment for prostate cancer.
  JAMA 2011 Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, Kaplan ID, Wood DP, Ciezki …
• Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation.
  PloS one 2011 Magbanua MJ, Roy R, Sosa EV, Weinberg V, Federman S, Mattie MD, Hughes-Fulford M, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM
• Vegetable and fruit intake after diagnosis and risk of prostate cancer progression.
  International journal of cancer 2011 Richman EL, Carroll PR, Chan JM
• Androgen deprivation therapy and cardiovascular risk.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Punnen S, Cooperberg MR, Sadetsky N, Carroll PR
• Active surveillance for prostate cancer: progress and promise.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Cooperberg MR, Carroll PR, Klotz L
• The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional study.
  The Journal of urology 2011 McKenney JK, Simko J, Bonham M, True LD, Troyer D, Hawley S, Newcomb LF, Fazli L, Kunju LP, Nicolas MM, Vakar-Lopez F, Zhang X, Carroll PR, Brooks JD, Canary/Early Detection Research Network Prostate …
• Treatment trends for stage I renal cell carcinoma.
  The Journal of urology 2011 Cooperberg MR, Mallin K, Kane CJ, Carroll PR
• The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy.
  Cancer 2011 Cooperberg MR, Hilton JF, Carroll PR
• Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Porten SP, Whitson JM, Cowan JE, Cooperberg MR, Shinohara K, Perez N, Greene KL, Meng MV, Carroll PR
• Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor.
  Cancer research 2011 Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM
• The contemporary concept of significant versus insignificant prostate cancer.
  European urology 2011 Ploussard G, Epstein JI, Montironi R, Carroll PR, Wirth M, Grimm MO, Bjartell AS, Montorsi F, Freedland SJ, Erbersdobler A, van der Kwast TH
• Factors associated with downgrading in patients with high grade prostate cancer.
  Urologic oncology 2011 Whitson JM, Porten SP, Cowan JE, Simko JP, Cooperberg MR, Carroll PR
• Editorial comment.
  Urology 2011 Carroll PR, Whitson JM
• Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment.
  BJU international 2011 Dall'Era MA, Cowan JE, Simko J, Shinohara K, Davies B, Konety BR, Meng MV, Perez N, Greene K, Carroll PR
• The relationship between prostate specific antigen change and biopsy progression in patients on active surveillance for prostate cancer.
  The Journal of urology 2011 Whitson JM, Porten SP, Hilton JF, Cowan JE, Perez N, Cooperberg MR, Greene KL, Meng MV, Simko JP, Shinohara K, Carroll PR
• Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007).
  The Journal of urology 2011 Mallin K, David KA, Carroll PR, Milowsky MI, Nanus DM
• Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry.
  Cancer 2011 Sadetsky N, Greene K, Cooperberg MR, Hubbard A, Carroll PR, Satariano W
• The example of CaPSURE: lessons learned from a national disease registry.
  World journal of urology 2011 Porten SP, Cooperberg MR, Konety BR, Carroll PR
• Prostate cancer: reducing overtreatment: active surveillance in low-risk disease.
  Nature reviews. Urology 2011 Whitson JM, Porten SP, Carroll PR
• Gentamicin pharmacokinetics in old age and frailty.
  British journal of clinical pharmacology 2011 Hilmer SN, Tran K, Rubie P, Wright J, Gnjidic D, Mitchell SJ, Matthews S, Carroll PR
• The needs for men undergoing active surveillance (AS) for prostate cancer: results of a focus group study.
  Journal of clinical nursing 2011 Kazer MW, Bailey DE, Colberg J, Kelly WK, Carroll P
• Oncological and functional outcomes of radical cystectomy and orthotopic bladder replacement in women.
  Urology 2011 Yang G, Whitson JM, Breyer BN, Konety BR, Carroll PR
• Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Carroll PR, Whitson JM, Cooperberg MR
• Urology resident publication output and its relationship to future academic achievement.
  The Journal of urology 2010 Yang G, Zaid UB, Erickson BA, Blaschko SD, Carroll PR, Breyer BN
• Impact of age at diagnosis on prostate cancer treatment and survival.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Bechis SK, Carroll PR, Cooperberg MR
• Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy.
  BJU international 2010 Breyer BN, Davis CB, Cowan JE, Kane CJ, Carroll PR
• Outcomes of active surveillance for men with intermediate-risk prostate cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll PR
• Inaccuracies in assignment of clinical stage for localized prostate cancer.
  Cancer 2010 Reese AC, Sadetsky N, Carroll PR, Cooperberg MR
• Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients.
  Cancer research 2010 Moltzahn F, Olshen AB, Baehner L, Peek A, Fong L, Stöppler H, Simko J, Hilton JF, Carroll P, Blelloch R
• Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer.
  Cancer causes & control : CCC 2010 Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, Shinohara K, Federman S, Mattie M, Hughes-Fulford M, Haqq C, Carroll PR
• Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.
  Cancer 2010 Cooperberg MR, Vickers AJ, Broering JM, Carroll PR
• Disproportionate presentation of high risk prostate cancer in a safety net health system.
  The Journal of urology 2010 Porten SP, Richardson DA, Odisho AY, McAninch JW, Carroll PR, Cooperberg MR
• Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE.
  BJU international 2010 Katz MS, Carroll PR, Cowan JE, Chan JM, D'Amico AV
• Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
  Urologic oncology 2010 Tasian GE, Cooperberg MR, Cowan JE, Keyashian K, Greene KL, Daniels NA, Carroll PR, Chan JM
• Electronic patient self-assessment and management (SAM): a novel framework for cancer survivorship.
  BMC medical informatics and decision making 2010 Vickers AJ, Salz T, Basch E, Cooperberg MR, Carroll PR, Tighe F, Eastham J, Rosen RC
• Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging.
  Radiology 2010 Fradet V, Kurhanewicz J, Cowan JE, Karl A, Coakley FV, Shinohara K, Carroll PR
• Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease.
  The Journal of urology 2010 Reese AC, Cooperberg MR, Carroll PR
• Active surveillance for early-stage prostate cancer: defining the triggers for intervention.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Whitson JM, Carroll PR
• Increased risk of high-grade prostate cancer among infertile men.
  Cancer 2010 Walsh TJ, Schembri M, Turek PJ, Chan JM, Carroll PR, Smith JF, Eisenberg ML, Van Den Eeden SK, Croughan MS
• Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo.
  British journal of cancer 2010 Bright SA, McElligott AM, O'Connell JW, O'Connor L, Carroll P, Campiani G, Deininger MW, Conneally E, Lawler M, Williams DC, Zisterer DM
• Urologist density and county-level urologic cancer mortality.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Odisho AY, Cooperberg MR, Fradet V, Ahmad AE, Carroll PR
• Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer.
  Cancer 2010 Fang AC, Ahmad AE, Whitson JM, Ferrell LD, Carroll PR, Konety BR
• The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer.
  BJU international 2010 Katz MS, Efstathiou JA, D'Amico AV, Kattan MW, Sanda MG, Nguyen PL, Smith MR, Carroll PR, Zietman AL
• Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer.
  Clinical oncology (Royal College of Radiologists (Great Britain)) 2010 Healy LA, Ryan AM, Carroll P, Ennis D, Crowley V, Boyle T, Kennedy MJ, Connolly E, Reynolds JV
• Changes in specific domains of sexual function and sexual bother after radical prostatectomy.
  BJU international 2010 Le JD, Cooperberg MR, Sadetsky N, Hittelman AB, Meng MV, Cowan JE, Latini DM, Carroll PR, CaPSURE Investigators
• NCCN clinical practice guidelines in oncology: prostate cancer early detection.
  Journal of the National Comprehensive Cancer Network : JNCCN 2010 Kawachi MH, Bahnson RR, Barry M, Busby JE, Carroll PR, Carter HB, Catalona WJ, Cookson MS, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP, Howe RJ, Lange PH, Lilja H, Loughlin KR, Mohler J, Moul J, …
• Time trends and local variation in primary treatment of localized prostate cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Cooperberg MR, Broering JM, Carroll PR
• Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA
• Eligibility for active surveillance and pathological outcomes for men undergoing radical prostatectomy in a large, community based cohort.
  The Journal of urology 2010 Smaldone MC, Cowan JE, Carroll PR, Davies BJ
• The impact of male circumcision on HIV transmission.
  The Journal of urology 2010 Doyle SM, Kahn JG, Hosang N, Carroll PR
• Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression.
  The American journal of clinical nutrition 2009 Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM
• Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy.
  NMR in biomedicine 2009 Santos CF, Kurhanewicz J, Tabatabai ZL, Simko JP, Keshari KR, Gbegnon A, Santos RD, Federman S, Shinohara K, Carroll PR, Haqq CM, Swanson MG
• A group of genome-based biomarkers that add to a Kattan nomogram for predicting progression in men with high-risk prostate cancer.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Paris PL, Weinberg V, Albo G, Roy R, Burke C, Simko J, Carroll P, Collins C
• Editorial comment.
  The Journal of urology 2009 Carroll PR
• Association of age and response to androgen-deprivation therapy with or without radiotherapy for prostate cancer: data from CaPSURE.
  BJU international 2009 Aaronson D, Cowan J, Carroll P, Konety B
• The adjunctive use of power Doppler imaging in the preoperative assessment of prostate cancer.
  BJU international 2009 Eisenberg ML, Cowan JE, Carroll PR, Shinohara K
• UroVysion testing can lead to early identification of intravesical therapy failure in patients with high risk non-muscle invasive bladder cancer.
  International braz j urol : official journal of the Brazilian Society of Urology 2009 Whitson JM, Berry AB, Carroll PR, Konety BR
• Patient decision aids for prostate cancer treatment: a systematic review of the literature.
  CA: a cancer journal for clinicians 2009 Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA
• Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: results from CaPSURE.
  Cancer 2009 Abouassaly R, Paciorek A, Ryan CJ, Carroll PR, Klein EA
• Prostate specific antigen best practice statement: 2009 update.
  The Journal of urology 2009 Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P
• Measuring illness uncertainty in men undergoing active surveillance for prostate cancer.
  Applied nursing research : ANR 2009 Bailey DE, Wallace M, Latini DM, Hegarty J, Carroll PR, Klein EA, Albertsen PC
• Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository.
  Urology 2009 Newcomb LF, Brooks JD, Carroll PR, Feng Z, Gleave ME, Nelson PS, Thompson IM, Lin DW
• Predictive value of serial measurements of quality of life on all-cause mortality in prostate cancer patients: data from CaPSURE (cancer of the prostate strategic urologic research endeavor) database.
  Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2009 Sadetsky N, Hubbard A, Carroll PR, Satariano W
• The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease.
  BJU international 2009 Porten SP, Cooperberg MR, Carroll PR
• Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Cooperberg MR, Hinotsu S, Namiki M, Ito K, Broering J, Carroll PR, Akaza H
• Prostate-cancer screening.
  The New England journal of medicine 2009 Cooperberg MR, Carroll PR
• Adequacy of lymphadenectomy among men undergoing robot-assisted laparoscopic radical prostatectomy.
  BJU international 2009 Cooperberg MR, Kane CJ, Cowan JE, Carroll PR
• Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.
  Journal of the National Cancer Institute 2009 Cooperberg MR, Broering JM, Carroll PR
• The impact of obesity on overall and cancer specific survival in men with prostate cancer.
  The Journal of urology 2009 Davies BJ, Smaldone MC, Sadetsky N, Dall'era M, Carroll PR
• Outcomes and follow-up strategies for patients on active surveillance.
  Current opinion in urology 2009 Dall'Era MA, Carroll PR
• ACR appropriateness criteria on external beam radiation therapy treatment planning for clinically localized prostate cancer expert panel on radiation oncology--prostate.
  International journal of radiation oncology, biology, physics 2009 Michalski JM, Roach M, Merrick G, Anscher MS, Beyer DC, Lawton CA, Lee WR, Pollack A, Rosenthal SA, Vijayakumar S, Carroll PR
• The importance of tumor palpability and transrectal ultrasonographic appearance in the contemporary clinical staging of prostate cancer.
  Urologic oncology 2009 Eisenberg ML, Cowan JE, Davies BJ, Carroll PR, Shinohara K
• Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy.
  European urology 2009 Eisenberg ML, Davies BJ, Cooperberg MR, Cowan JE, Carroll PR
• Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
  Cancer 2009 David KA, Mallin K, Milowsky MI, Ritchey J, Carroll PR, Nanus DM
• Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer.
  BMC cancer 2009 Ross PL, Cheng I, Liu X, Cicek MS, Carroll PR, Casey G, Witte JS
• Maximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapy.
  International journal of radiation oncology, biology, physics 2009 Chen RC, Sadetsky N, Chen MH, Carroll PR, D'Amico AV
• Pathological outcomes of candidates for active surveillance of prostate cancer.
  The Journal of urology 2009 Conti SL, Dall'era M, Fradet V, Cowan JE, Simko J, Carroll PR
• Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease.
  The Journal of urology 2009 Dall'era MA, Hosang N, Konety B, Cowan JE, Carroll PR
• A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy.
  BJU international 2009 Whitson J, Berry A, Carroll P, Konety B
• Are age-based criteria the best way to determine eligibility for prostate cancer screening?
  Annals of internal medicine 2009 Konety BR, Cooperberg MR, Carroll PR
• Sequential intravesical gemcitabine and mitomycin C chemotherapy regimen in patients with non-muscle invasive bladder cancer.
  Urologic oncology 2009 Breyer BN, Whitson JM, Carroll PR, Konety BR
• The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer.
  European urology 2009 Karl A, Carroll PR, Gschwend JE, Knüchel R, Montorsi F, Stief CG, Studer UE
• Geographic distribution of urologists throughout the United States using a county level approach.
  The Journal of urology 2008 Odisho AY, Fradet V, Cooperberg MR, Ahmad AE, Carroll PR
• The clinical impact of an early decline in kidney function in patients following heart transplantation.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008 Cantarovich M, Hirsh A, Alam A, Giannetti N, Cecere R, Carroll P, Edwardes ME
• Conventional treatments of localized prostate cancer.
  Urology 2008 Zerbib M, Zelefsky MJ, Higano CS, Carroll PR
• Evaluating localized prostate cancer and identifying candidates for focal therapy.
  Urology 2008 Sartor AO, Hricak H, Wheeler TM, Coleman J, Penson DF, Carroll PR, Rubin MA, Scardino PT
• New treatments for localized prostate cancer.
  Urology 2008 Marberger M, Carroll PR, Zelefsky MJ, Coleman JA, Hricak H, Scardino PT, Abenhaim LL
• Pretreatment predictors of death from other causes in men with prostate cancer.
  The Journal of urology 2008 Simone NL, Singh AK, Cowan JE, Soule BP, Carroll PR, Litwin MS
• Health related quality of life in patients treated with multimodal therapy for prostate cancer.
  The Journal of urology 2008 Wu AK, Cooperberg MR, Sadetsky N, Carroll PR
• Quality of life in men with locally advanced adenocarcinoma of the prostate: an exploratory analysis using data from the CaPSURE database.
  The Journal of urology 2008 White WM, Sadetsky N, Waters WB, Carroll PR, Litwin MS
• Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks.
  European urology 2008 Isbarn H, Boccon-Gibod L, Carroll PR, Montorsi F, Schulman C, Smith MR, Sternberg CN, Studer UE
• Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: results from CaPSURE.
  Urologic oncology 2008 Hong YM, Hu JC, Paciorek AT, Knight SJ, Carroll PR
• Increased telomerase activity and comprehensive lifestyle changes: a pilot study.
  The Lancet. Oncology 2008 Ornish D, Lin J, Daubenmier J, Weidner G, Epel E, Kemp C, Magbanua MJ, Marlin R, Yglecias L, Carroll PR, Blackburn EH
• An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer.
  Prostate cancer and prostatic diseases 2008 Paris PL, Sridharan S, Hittelman AB, Kobayashi Y, Perner S, Huang G, Simko J, Carroll P, Rubin MA, Collins C
• What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
  The Journal of urology 2008 Barocas DA, Cowan JE, Smith JA, Carroll PR, CaPSURE Investigators
• Clinical events in prostate cancer lifestyle trial: results from two years of follow-up.
  Urology 2008 Frattaroli J, Weidner G, Dnistrian AM, Kemp C, Daubenmier JJ, Marlin RO, Crutchfield L, Yglecias L, Carroll PR, Ornish D
• Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy.
  Magnetic resonance in medicine 2008 Swanson MG, Keshari KR, Tabatabai ZL, Simko JP, Shinohara K, Carroll PR, Zektzer AS, Kurhanewicz J
• Renal cell cancer stage migration: analysis of the National Cancer Data Base.
  Cancer 2008 Kane CJ, Mallin K, Ritchey J, Cooperberg MR, Carroll PR
• Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention.
  Proceedings of the National Academy of Sciences of the United States of America 2008 Ornish D, Magbanua MJ, Weidner G, Weinberg V, Kemp C, Green C, Mattie MD, Marlin R, Simko J, Shinohara K, Haqq CM, Carroll PR
• Active surveillance for the management of prostate cancer in a contemporary cohort.
  Cancer 2008 Dall'Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR
• Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004.
  The Journal of urology 2008 Cooperberg MR, Mallin K, Ritchey J, Villalta JD, Carroll PR, Kane CJ
• Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance?
  Radiology 2008 Cabrera AR, Coakley FV, Westphalen AC, Lu Y, Zhao S, Shinohara K, Carroll PR, Kurhanewicz J
• Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE.
  The Journal of urology 2008 Arredondo SA, Downs TM, Lubeck DP, Pasta DJ, Silva SJ, Wallace KL, Carroll PR
• Active surveillance for early-stage prostate cancer: review of the current literature.
  Cancer 2008 Dall'Era MA, Cooperberg MR, Chan JM, Davies BJ, Albertsen PC, Klotz LH, Warlick CA, Holmberg L, Bailey DE, Wallace ME, Kantoff PW, Carroll PR
• High-risk prostate cancer in the United States, 1990-2007.
  World journal of urology 2008 Cooperberg MR, Cowan J, Broering JM, Carroll PR
• Racial differences among boys with testicular germ cell tumors in the United States.
  The Journal of urology 2008 Walsh TJ, Davies BJ, Croughan MS, Carroll PR, Turek PJ
• Fear of recurrence, symptom burden, and health-related quality of life in men with prostate cancer.
  Urology 2008 Bellizzi KM, Latini DM, Cowan JE, DuChane J, Carroll PR
• Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE.
  The Journal of urology 2008 Konety BR, Cowan JE, Carroll PR, CaPSURE Investigators
• Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993-2004.
  The Journal of urology 2008 Woldrich JM, Mallin K, Ritchey J, Carroll PR, Kane CJ
• Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
  BJU international 2008 Sadetsky N, Lubeck DP, Pasta DJ, Latini DM, DuChane J, Carroll PR
• Effect of BMI on primary treatment of prostate cancer.
  Urology 2008 Davies BJ, Walsh TJ, Ross PL, Knight SJ, Sadetsky N, Carroll PR, Kane CJ
• A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy.
  The Journal of urology 2008 Choueiri TK, Dreicer R, Paciorek A, Carroll PR, Konety B
• The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitors.
  The Journal of urology 2008 Lee IH, Sadetsky N, Carroll PR, Sandler HM
• Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes.
  Cancer 2008 Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR, Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE)
• Multiparametric magnetic resonance imaging in prostate cancer: present and future.
  Current opinion in urology 2008 Kurhanewicz J, Vigneron D, Carroll P, Coakley F
• Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality.
  Urology 2008 Chung CS, Chen MH, Cullen J, McLeod D, Carroll P, D'Amico AV
• Predicting PSA failure following salvage radiotherapy for a rising PSA post-prostatectomy: from the CaPSURE database.
  Urologic oncology 2007 Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll PR
• Prostate cancer in the Baby Boomer generation: results from CaPSURE.
  Urology 2007 Scales CD, Moul JW, Curtis LH, Elkin EP, Hughes ME, Carroll PR, CaPSURE Investigators
• Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging.
  Radiology 2007 Westphalen AC, Coakley FV, Qayyum A, Swanson M, Simko JP, Lu Y, Zhao S, Carroll PR, Yeh BM, Kurhanewicz J
• Prostate biopsy patterns in the CaPSURE database: evolution with time and impact on outcome after prostatectomy.
  The Journal of urology 2007 Shah JB, McKiernan JM, Elkin EP, Carroll PR, Meng MV, CaPSURE Investigators
• Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
  The Journal of urology 2007 Eggener SE, Scardino PT, Carroll PR, Zelefsky MJ, Sartor O, Hricak H, Wheeler TM, Fine SW, Trachtenberg J, Rubin MA, Ohori M, Kuroiwa K, Rossignol M, Abenhaim L, International Task Force on Prostate …
• Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
  Journal of the National Cancer Institute 2007 Tsai HK, D'Amico AV, Sadetsky N, Chen MH, Carroll PR
• Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
  Prostate cancer and prostatic diseases 2007 Sadetsky N, Elkin EP, Latini DM, DuChane J, Carroll PR, CaPSURE Investigators
• Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer.
  The Journal of urology 2007 Walsh TJ, Dall'Era MA, Croughan MS, Carroll PR, Turek PJ
• Prostate cancer early detection. Clinical practice guidelines in oncology.
  Journal of the National Comprehensive Cancer Network : JNCCN 2007 Kawachi MH, Bahnson RR, Barry M, Carroll PR, Carter HB, Catalona WJ, Epstein JI, Etzioni RB, Hemstreet GP, Howe RJ, Kopin JD, Lange PH, Lilja H, Mohler J, Moul J, Nadler RB, Patterson S, Pollack A, …
• Prostate-specific antigen level at initiation of hormonal therapy after prostate-specific antigen failure following prostatectomy or radiotherapy and therapeutic response.
  Urology 2007 Alexander BM, Chen MH, Carroll P, D'Amico AV
• Contemporary trends in low risk prostate cancer: risk assessment and treatment.
  The Journal of urology 2007 Cooperberg MR, Broering JM, Kantoff PW, Carroll PR
• Innovations and challenges in prostate cancer: summary statement for the 6th Cambridge Conference.
  The Journal of urology 2007 Kantoff PW, Beer TM, D'Amico AV, Dipaola RS, Eisenberger MA, Hussain MH, Kelly WK, Mathew P, Morris MJ, Ryan CJ, Sandler HM, Thompson IM, Carroll PR
• Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer.
  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2007 Hart SL, Latini DM, Cowan JE, Carroll PR, CaPSURE Investigators
• The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance.
  The Journal of urology 2007 Latini DM, Hart SL, Knight SJ, Cowan JE, Ross PL, Duchane J, Carroll PR, CaPSURE Investigators
• Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database.
  Urology 2007 Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll PR
• Initial treatment patterns and outcome of contemporary prostate cancer patients with bone metastases at initial presentation: data from CaPSURE.
  Cancer 2007 Ryan CJ, Elkin EP, Cowan J, Carroll PR
• Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
  The Journal of urology 2007 Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll PR, CaPSURE Investigators
• Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
  The Journal of urology 2007 David KA, Milowsky MI, Ritchey J, Carroll PR, Nanus DM
• Quality of life in young men after radical prostatectomy.
  Prostate cancer and prostatic diseases 2007 Wright JL, Lin DW, Cowan JE, Carroll PR, Litwin MS, CaPSURE Investigators
• Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: a longitudinal quality of life analysis from CaPSURE.
  Cancer 2007 Knight SJ, Latini DM, Hart SL, Sadetsky N, Kane CJ, DuChane J, Carroll PR, CaPSURE Investigators
• Prostate cancer--more information and more questions.
  The Journal of urology 2007 Dall'Era M, Carroll PR
• Prostate brachytherapy: a descriptive analysis from CaPSURE.
  Brachytherapy 2007 Lee WR, Sharkey J, Cowan JE, DuChane J, Carroll PR, CaPSURE Investigators
• Recovery of urinary continence following radical prostatectomy: the impact of prostate volume--analysis of data from the CaPSURE Database.
  The Journal of urology 2007 Konety BR, Sadetsky N, Carroll PR, CaPSURE Investigators
• Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality.
  Cancer 2007 D'Amico AV, McLeod DG, Carroll PR, Cullen J, Chen MH
• Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor.
  The Journal of urology 2007 Boorjian S, Cowan JE, Konety BR, DuChane J, Tewari A, Carroll PR, Kane CJ, Cancer of the Prostate Strategic Urologic Research Endeavor Investigators
• Cumulative cost pattern comparison of prostate cancer treatments.
  Cancer 2007 Wilson LS, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll PR
• Factors affecting outcomes after radical cystectomy in African Americans.
  Cancer 2007 Konety BR, Allareddy V, Carroll PR
• Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE.
  The Journal of urology 2007 Berglund RK, Sadetsky N, DuChane J, Carroll PR, Klein EA
• Quality of life for men receiving a second treatment for prostate cancer.
  The Journal of urology 2007 Arredondo SA, Latini DM, Sadetsky N, Kawakami J, Pasta DJ, DuChane J, Carroll PR, CaPSURE Investigators
• Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the Prostate Cancer Lifestyle Trial.
  Nutrition and cancer 2007 Dewell A, Weidner G, Sumner MD, Barnard RJ, Marlin RO, Daubenmier JJ, Chi C, Carroll PR, Ornish D
• Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging.
  BJU international 2007 Coakley FV, Chen I, Qayyum A, Westphalen AC, Carroll PR, Hricak H, Chen MH, Kurhanewicz J
• High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience.
  Radiology 2006 Hom JJ, Coakley FV, Simko JP, Lu Y, Qayyum A, Westphalen AC, Schmitt LD, Carroll PR, Kurhanewicz J
• Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE.
  Urology 2006 Latini DM, Chan JM, Cowan JE, Arredondo SA, Kane CJ, Penson DF, DuChane J, Carroll PR, CaPSURE Investigators
• Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer.
  Cancer 2006 Tsai HK, Chen MH, McLeod DG, Carroll PR, Richie JP, D'Amico AV
• Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancer.
  Neoplasia (New York, N.Y.) 2006 Paris PL, Hofer MD, Albo G, Kuefer R, Gschwend JE, Hautmann RE, Fridyland J, Simko J, Carroll PR, Rubin MA, Collins C
• Recommendations for defining and treating high risk localized prostate cancer.
  The Journal of urology 2006 Thompson IM, Carroll PR, Carducci MA
• Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy.
  Cancer 2006 Cooperberg MR, Freedland SJ, Pasta DJ, Elkin EP, Presti JC, Amling CL, Terris MK, Aronson WJ, Kane CJ, Carroll PR
• Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE.
  The Journal of urology 2006 Kawakami J, Meng MV, Sadetsky N, Latini DM, Duchane J, Carroll PR, CaPSURE Investigators
• Reduced incidence of bony metastasis at initial prostate cancer diagnosis: data from CaPSURE.
  Urologic oncology 2006 Ryan CJ, Elkin EP, Small EJ, Duchane J, Carroll P
• Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality.
  Urology 2006 Efstathiou JA, Chen MH, Catalona WJ, McLeod DG, Carroll PR, Moul JW, Roehl KA, D'Amico AV
• Impact of increased number of biopsies on the nature of prostate cancer identified.
  The Journal of urology 2006 Meng MV, Elkin EP, DuChane J, Carroll PR
• Laparoscopic versus open cytoreductive nephrectomy in advanced renal-cell carcinoma.
  Journal of endourology 2006 Eisenberg MS, Meng MV, Master VA, Stoller ML, Rini BI, Carroll PR, Kane CJ
• Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy.
  Magnetic resonance in medicine 2006 Swanson MG, Zektzer AS, Tabatabai ZL, Simko J, Jarso S, Keshari KR, Schmitt L, Carroll PR, Shinohara K, Vigneron DB, Kurhanewicz J
• Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
  Cancer 2006 Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR, CaPSURE Investigators
• Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE.
  The Journal of urology 2006 Marr PL, Elkin EP, Arredondo SA, Broering JM, DuChane J, Carroll PR
• Impact of comorbidity on health-related quality of life in men undergoing radical prostatectomy: data from CaPSURE.
  Urology 2006 Arredondo SA, Elkin EP, Marr PL, Latini DM, DuChane J, Litwin MS, Carroll PR, CaPSURE Investigators
• Modifying urology residency training: time to speed up or slow down?
  The Journal of urology 2006 Carroll PR
• Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE.
  Cancer 2006 Latini DM, Elkin EP, Cooperberg MR, Sadetsky N, Duchane J, Carroll PR
• Elongational flow induced ordering in surfactant micelles and mesophases.
  The journal of physical chemistry. B 2006 Penfold J, Staples E, Tucker I, Carroll P, Clayton I, Cowan JS, Lawton G, Amin S, Ferrante A, Ruddock N
• Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance.
  Urology 2006 Daubenmier JJ, Weidner G, Marlin R, Crutchfield L, Dunn-Emke S, Chi C, Gao B, Carroll P, Ornish D
• Magnetic resonance imaging and spectroscopy of prostate cancer.
  Reviews in urology 2006 Carroll PR, Coakley FV, Kurhanewicz J
• Prostate biopsy tumor extent but not location predicts recurrence after radical prostatectomy: results from CaPSURE.
  The Journal of urology 2006 Greene KL, Elkin EP, Karapetian A, Duchane J, Carroll PR, Kane CJ, CaPSURE Investigators
• Prostate cancer: endorectal MR imaging and MR spectroscopic imaging--distinction of true-positive results from chance-detected lesions.
  Radiology 2006 Hom JJ, Coakley FV, Simko JP, Qayyum A, Lu Y, Schmitt L, Carroll PR, Kurhanewicz J
• Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma.
  Cancer 2006 Enokida H, Shiina H, Urakami S, Terashima M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Igawa M, Dahiya R
• Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer.
  Urology 2005 Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR
• The changing face of prostate cancer.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 Cooperberg MR, Moul JW, Carroll PR
• Androgen deprivation use with external beam radiation for prostate cancer: results from CaPSURE.
  The Journal of urology 2005 Park S, Meng MV, Elkin EP, Speight JL, DuChane J, Carroll PR
• Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
  Urology 2005 Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll PR, Kane CJ
• The independent impact of extended pattern biopsy on prostate cancer stage migration.
  The Journal of urology 2005 Master VA, Chi T, Simko JP, Weinberg V, Carroll PR
• Who is the average patient presenting with prostate cancer?
  Urology 2005 Greene KL, Cowan JE, Cooperberg MR, Meng MV, DuChane J, Carroll PR, Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) Investigators
• Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer.
  Oncogene 2005 Ogishima T, Shiina H, Breault JE, Terashima M, Honda S, Enokida H, Urakami S, Tokizane T, Kawakami T, Ribeiro-Filho LA, Fujime M, Kane CJ, Carroll PR, Igawa M, Dahiya R
• Bladder cancer stage and outcome by array-based comparative genomic hybridization.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T, Pejavar S, Mehta K, Carroll P, Simko JP, Waldman FM
• Ethnic and racial differences in prostate stromal estrogen receptor alpha.
  The Prostate 2005 Haqq C, Li R, Khodabakhsh D, Frolov A, Ginzinger D, Thompson T, Wheeler T, Carroll P, Ayala G
• Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 Zhou P, Chen MH, McLeod D, Carroll PR, Moul JW, D'Amico AV
• Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 Stewart AJ, Scher HI, Chen MH, McLeod DG, Carroll PR, Moul JW, D'Amico AV
• Multigene methylation analysis for detection and staging of prostate cancer.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R
• History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States).
  Cancer causes & control : CCC 2005 Chan JM, Latini DM, Cowan J, Duchane J, Carroll PR
• Intensive lifestyle changes may affect the progression of prostate cancer.
  The Journal of urology 2005 Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB, Raisin CJ, Dunn-Emke S, Crutchfield L, Jacobs FN, Barnard RJ, Aronson WJ, McCormac P, McKnight DJ, Fein JD, Dnistrian AM, Weinstein J, Ngo TH, …
• Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer.
  International journal of cancer 2005 Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Pookot D, Li LC, Tabatabai ZL, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R
• Management of isolated renal fossa recurrence following radical nephrectomy.
  The Journal of urology 2005 Master VA, Gottschalk AR, Kane C, Carroll PR
• Clinical and pathological characteristics of unstageable prostate cancer: analysis of the CaPSURE database.
  The Journal of urology 2005 Langenstroer P, Carroll P, Thrasher JB
• CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer.
  Cancer 2005 Zhao H, Shiina H, Greene KL, Li LC, Tanaka Y, Kishi H, Igawa M, Kane CJ, Carroll P, Dahiya R
• Preliminary evaluation of prostate cancer metastatic risk biomarkers.
  The International journal of biological markers 2005 Paris PL, Weinberg V, Simko J, Andaya A, Albo G, Rubin MA, Carroll PR, Collins C
• Update on chemotherapy for advanced bladder cancer.
  The Journal of urology 2005 Rosenberg JE, Carroll PR, Small EJ
• Bladder cancer outcome and subtype classification by gene expression.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Blaveri E, Simko JP, Korkola JE, Brewer JL, Baehner F, Mehta K, Devries S, Koppie T, Pejavar S, Carroll P, Waldman FM
• The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy.
  The Journal of urology 2005 Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR
• Multidisciplinary management of advanced prostate cancer: changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials.
  Urology 2005 Carducci MA, Carroll PR
• Surrogate end point for prostate cancer specific mortality in patients with nonmetastatic hormone refractory prostate cancer.
  The Journal of urology 2005 D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH
• Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE).
  The Journal of urology 2005 Meng MV, Elkin EP, Latini DM, Duchane J, Carroll PR
• Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
  The Journal of urology 2005 Mitchell JA, Cooperberg MR, Elkin EP, Lubeck DP, Mehta SS, Kane CJ, Carroll PR
• Early stage prostate cancer--do we have a problem with over-detection, overtreatment or both?
  The Journal of urology 2005 Carroll PR
• The impact of obesity on health related quality of life before and after radical prostatectomy (data from CaPSURE).
  The Journal of urology 2005 Anast JW, Sadetsky N, Pasta DJ, Bassett WW, Latini D, DuChane J, Chan JM, Cooperberg MR, Carroll PR, Kane CJ
• CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells.
  International journal of cancer 2005 Retz MM, Sidhu SS, Blaveri E, Kerr SC, Dolganov GM, Lehmann J, Carroll P, Simko J, Waldman FM, Basbaum C
• Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer.
  Cancer research 2005 Shiina H, Breault JE, Basset WW, Enokida H, Urakami S, Li LC, Okino ST, Deguchi M, Kaneuchi M, Terashima M, Yoneda T, Shigeno K, Carroll PR, Igawa M, Dahiya R
• Lifestyle correlates of health perception and treatment satisfaction in a clinical cohort of men with prostate cancer.
  Clinical prostate cancer 2005 Sheriff SK, Shohara RA, Dumican SB, Small EJ, Carroll PR, Chan JM
• Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE.
  The Journal of urology 2005 Kane CJ, Bassett WW, Sadetsky N, Silva S, Wallace K, Pasta DJ, Cooperberg MR, Chan JM, Carroll PR
• Demographics, insurance coverage, and utilization of medical services in newly diagnosed prostate cancer: data from caPSURE.
  Managed care interface 2005 Sadetsky N, Lubeck DP, Latini DM, Pasta DJ, Kawakami J, DuChane J, Carroll PR, Capsure Investigators
• Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
  Journal of the National Cancer Institute 2005 Li LC, Carroll PR, Dahiya R
• Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Breault JE, Shiina H, Igawa M, Ribeiro-Filho LA, Deguchi M, Enokida H, Urakami S, Terashima M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R
• Inactivation of the hMSH3 mismatch repair gene in bladder cancer.
  Biochemical and biophysical research communications 2004 Kawakami T, Shiina H, Igawa M, Deguchi M, Nakajima K, Ogishima T, Tokizane T, Urakami S, Enokida H, Miura K, Ishii N, Kane CJ, Carroll PR, Dahiya R
• Ferromagnetic thermal ablation of locally recurrent prostate cancer: prostate specific antigen results and immediate/intermediate morbidities.
  The Journal of urology 2004 Master VA, Shinohara K, Carroll PR
• Kidney gene database: a curated and integrated database of genes involved in kidney disease.
  The Journal of urology 2004 Zhao H, Li LC, Okino ST, Kane CJ, Carroll PR, Dahiya R
• Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system.
  Radiology 2004 Jung JA, Coakley FV, Vigneron DB, Swanson MG, Qayyum A, Weinberg V, Jones KD, Carroll PR, Kurhanewicz J
• Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSURE.
  International journal of radiation oncology, biology, physics 2004 Speight JL, Elkin EP, Pasta DJ, Silva S, Lubeck DP, Carroll PR, Litwin MS
• Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment.
  The Journal of urology 2004 Carroll PR, Chan JM, D'Amico AV, Gelmann EP, Iversen P, Klotz L, Nelson JB, Nelson PS, Nelson WG, Oh WK, Rosen N, Rubin MA, Sandler H, Sellers WR, Smith MR, Xu J, McMann MC, Kantoff PW
• Prostate specific antigen doubling time as a surrogate end point for prostate cancer specific mortality following radical prostatectomy or radiation therapy.
  The Journal of urology 2004 D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH
• The impact of patient advocacy: the University of California-San Francisco experience.
  The Journal of urology 2004 Carroll PR, Prostate Cancer Advocates
• The relative impact and future burden of prostate cancer in the United States.
  The Journal of urology 2004 Chan JM, Jou RM, Carroll PR
• Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE.
  The Journal of urology 2004 Arredondo SA, Downs TM, Lubeck DP, Pasta DJ, Silva SJ, Wallace KL, Carroll PR
• Molecular analysis of WFDC1/ps20 gene in prostate cancer.
  The Prostate 2004 Watson JE, Kamkar S, James K, Kowbel D, Andaya A, Paris PL, Simko J, Carroll P, McAlhany S, Rowley D, Collins C
• Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging.
  AJR. American journal of roentgenology 2004 Qayyum A, Coakley FV, Lu Y, Olpin JD, Wu L, Yeh BM, Carroll PR, Kurhanewicz J
• CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
  Cancer research 2004 Enokida H, Shiina H, Igawa M, Ogishima T, Kawakami T, Bassett WW, Anast JW, Li LC, Urakami S, Terashima M, Verma M, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R
• Prostate cancer 2004: insights from national disease registries.
  Oncology (Williston Park, N.Y.) 2004 Cooperberg MR, Park S, Carroll PR
• Age-dependent methylation of ESR1 gene in prostate cancer.
  Biochemical and biophysical research communications 2004 Li LC, Shiina H, Deguchi M, Zhao H, Okino ST, Kane CJ, Carroll PR, Igawa M, Dahiya R
• Distribution of a single nucleotide polymorphism on codon 211 of the androgen receptor gene and its correlation with human renal cell cancer in Japanese patients.
  Biochemical and biophysical research communications 2004 Sasaki M, Nomoto M, Yonezawa S, Nakagawa M, Sakuragi N, Fujimoto S, Carroll PR, Dahiya R
• Patterns of practice in the United States: insights from CaPSURE on prostate cancer management.
  Current urology reports 2004 Cooperberg MR, Broering JM, Latini DM, Litwin MS, Wallace KL, Carroll PR
• The changing face of low-risk prostate cancer: trends in clinical presentation and primary management.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004 Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR
• Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure).
  The Journal of urology 2004 Greene KL, Meng MV, Elkin EP, Cooperberg MR, Pasta DJ, Kattan MW, Wallace K, Carroll PR
• Mutation of the slow myosin heavy chain rod domain underlies hyaline body myopathy.
  Neurology 2004 Bohlega S, Abu-Amero SN, Wakil SM, Carroll P, Al-Amr R, Lach B, Al-Sayed Y, Cupler EJ, Meyer BF
• Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors.
  Human molecular genetics 2004 Paris PL, Andaya A, Fridlyand J, Jain AN, Weinberg V, Kowbel D, Brebner JH, Simko J, Watson JE, Volik S, Albertson DG, Pinkel D, Alers JC, van der Kwast TH, Vissers KJ, Schroder FH, Wildhagen MF, …
• Lifestyle recommendations to prevent prostate cancer, part I: time to redirect our attention?
  The Urologic clinics of North America 2004 Moyad MA, Carroll PR
• Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention?
  The Urologic clinics of North America 2004 Moyad MA, Carroll PR
• Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure.
  Journal of the National Cancer Institute 2004 D'Amico AV, Moul JW, Carroll PR, Cote K, Sun L, Lubeck D, Renshaw AA, Loffredo M, Chen MH
• Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
  The Prostate 2004 Strohmeyer DM, Berger AP, Moore DH, Bartsch G, Klocker H, Carroll PR, Loening SA, Jensen RH
• Radical retropubic prostatectomy frustrated by prior laparoscopic mesh herniorrhaphy.
  Surgery 2004 Cooperberg MR, Downs TM, Carroll PR
• The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.
  The Journal of urology 2004 Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR, CaPSURE Investigators
• Evaluation of the patient with hematuria.
  The Medical clinics of North America 2004 Yun EJ, Meng MV, Carroll PR
• Treatment and outcome of invasive bladder cancer in patients after renal transplantation.
  The Journal of urology 2004 Master VA, Meng MV, Grossfeld GD, Koppie TM, Hirose R, Carroll PR
• Laparoscopic partial nephrectomy with temporary arterial occlusion: description of technique and renal functional outcomes.
  Urology 2004 Kane CJ, Mitchell JA, Meng MV, Anast J, Carroll PR, Stoller ML
• Predicting quality of life after radical prostatectomy: results from CaPSURE.
  The Journal of urology 2004 Hu JC, Elkin EP, Pasta DJ, Lubeck DP, Kattan MW, Carroll PR, Litwin MS
• Patterns of secondary cancer treatment for biochemical failure following radical prostatectomy: data from CaPSURE.
  The Journal of urology 2004 Mehta SS, Lubeck DP, Sadetsky N, Pasta DJ, Carroll PR
• Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy.
  Radiology 2004 Dhingsa R, Qayyum A, Coakley FV, Lu Y, Jones KD, Swanson MG, Carroll PR, Hricak H, Kurhanewicz J
• The polyglycine and polyglutamine repeats in the androgen receptor gene in Japanese and Caucasian populations.
  Biochemical and biophysical research communications 2003 Sasaki M, Kaneuchi M, Sakuragi N, Fujimoto S, Carroll PR, Dahiya R
• Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE.
  Urology 2003 Kane CJ, Lubeck DP, Knight SJ, Spitalny M, Downs TM, Grossfeld GD, Pasta DJ, Mehta SS, Carroll PR
• Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSURE.
  The Journal of urology 2003 Meng MV, Elkin EP, Harlan SR, Mehta SS, Lubeck DP, Carroll PR
• The evolving role of androgen deprivation therapy in the management of prostate cancer.
  Minerva urologica e nefrologica = The Italian journal of urology and nephrology 2003 Cooperberg MR, Small EJ, D'Amico A, Carroll PR
• Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatment.
  The Journal of urology 2003 Carroll PR, Benaron DA, Blackledge G, Coakley FV, D'Amico AV, Higano CS, Iversen P, Kattan M, Nanus DM, Nelson JB, Oh WK, Roach M, Sellers WR, Smith MR, McMann MC, Kantoff PW
• Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).
  The Journal of urology 2003 Cooperberg MR, Lubeck DP, Mehta SS, Carroll PR, CaPSURE
• Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer--data from CaPSURE.
  The Journal of urology 2003 Downs TM, Sadetsky N, Pasta DJ, Grossfeld GD, Kane CJ, Mehta SS, Carroll PR, Lubeck DP
• Proton HR-MAS spectroscopy and quantitative pathologic analysis of MRI/3D-MRSI-targeted postsurgical prostate tissues.
  Magnetic resonance in medicine 2003 Swanson MG, Vigneron DB, Tabatabai ZL, Males RG, Schmitt L, Carroll PR, James JK, Hurd RE, Kurhanewicz J
• Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
  The Journal of urology 2003 Harlan SR, Cooperberg MR, Elkin E, Lubeck DP, Meng M, Mehta SS, Carroll PR
• Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy.
  Journal of the National Cancer Institute 2003 D'Amico AV, Moul JW, Carroll PR, Sun L, Lubeck D, Chen MH
• Mouse urogenital development: a practical approach.
  Differentiation; research in biological diversity 2003 Staack A, Donjacour AA, Brody J, Cunha GR, Carroll P
• Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CaPSURE.
  The Journal of urology 2003 Cooperberg M, Lubeck DP, Penson D, Mehta SS, Carroll PR, Kane CJ
• Health related quality of life significance of single pad urinary incontinence following radical prostatectomy.
  The Journal of urology 2003 Cooperberg MR, Master VA, Carroll PR
• National practice patterns and time trends in androgen ablation for localized prostate cancer.
  Journal of the National Cancer Institute 2003 Cooperberg MR, Grossfeld GD, Lubeck DP, Carroll PR
• Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors.
  Cancer research 2003 Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN, Waldman FM
• Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003 D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH
• Imaging clinically localized prostate cancer.
  The Urologic clinics of North America 2003 Purohit RS, Shinohara K, Meng MV, Carroll PR
• Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2.
  Biochemical and biophysical research communications 2003 Patra SK, Patra A, Zhao H, Carroll P, Dahiya R
• High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays.
  The American journal of pathology 2003 Paris PL, Albertson DG, Alers JC, Andaya A, Carroll P, Fridlyand J, Jain AN, Kamkar S, Kowbel D, Krijtenburg PJ, Pinkel D, Schröder FH, Vissers KJ, Watson VJ, Wildhagen MF, Collins C, Van Dekken H
• Quantitation of apoptotic activity following castration in human prostatic tissue in vivo.
  The Prostate 2003 Staack A, Kassis AP, Olshen A, Wang Y, Wu D, Carroll PR, Grossfeld GD, Cunha GR, Hayward SW
• Fourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim/oim mice.
  Calcified tissue international 2003 Camacho NP, Carroll P, Raggio CL
• Health-related quality of life in men with metastatic prostate cancer: the misleading effect of lead-time bias.
  BJU international 2003 Litwin MS, Saigal CS, Lubeck DP, Li YP, Henning JM, Carroll PR
• How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE.
  Urology 2003 Cooperberg MR, Koppie TM, Lubeck DP, Ye J, Grossfeld GD, Mehta SS, Carroll PR, CaPSURE
• Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer.
  The Journal of urology 2003 Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carroll PR
• Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?
  The Journal of urology 2002 Grossfeld GD, Latini DM, Downs T, Lubeck DP, Mehta SS, Carroll PR
• Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109.
  The Journal of urology 2002 Powell IJ, Tangen CM, Miller GJ, Lowe BA, Haas G, Carroll PR, Osswald MB, DeVERE WHITE R, Thompson IM, Crawford ED
• Sociodemographic characteristics and health related quality of life in men attending prostate cancer support groups.
  The Journal of urology 2002 Katz D, Koppie TM, Wu D, Meng MV, Grossfeld GD, Sadesky N, Lubeck DP, Carroll PR
• A review of measurement of patient preferences for treatment outcomes after prostate cancer.
  Urology 2002 Lubeck DP, Grossfeld GD, Carroll PR
• Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer.
  Urology 2002 Meng MV, Grossfeld GD, Sadetsky N, Mehta SS, Lubeck DP, Carroll PR
• Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer.
  Urology 2002 Carroll PR, Kantoff PW, Balk SP, Brown MA, D'amico AV, George DJ, Grossfeld GD, Johnson CS, Kelly WK, Klotz L, Lee WR, Lubeck DP, Mcleod DG, Oh WK, Pollack A, Sartor O, Smith MR, Hart C, Second …
• Patterns of failure after primary local therapy for prostate cancer and rationale for secondary therapy.
  Urology 2002 Grossfeld GD, Li YP, P Lubeck DP, Carroll PR
• Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor.
  The Journal of urology 2002 Cooperberg MR, Lubeck DP, Grossfeld GD, Mehta SS, Carroll PR
• CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
  Molecular carcinogenesis 2002 Ribeiro-Filho LA, Franks J, Sasaki M, Shiina H, Li LC, Nojima D, Arap S, Carroll P, Enokida H, Nakagawa M, Yonezawa S, Dahiya R
• Neoadjuvant strategies for prostate cancer prior to radical prostatectomy.
  Seminars in urologic oncology 2002 Meng MV, Grossfeld GD, Carroll PR, Small EJ
• Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
  The Journal of urology 2002 Grossfeld GD, Li YP, Lubeck DP, Broering JM, Mehta SS, Carroll PR
• Mental health in men treated for early stage prostate carcinoma: a posttreatment, longitudinal quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor.
  Cancer 2002 Litwin MS, Lubeck DP, Spitalny GM, Henning JM, Carroll PR
• Sextant prostate biopsies predict side and sextant site of extracapsular extension of prostate cancer.
  The Journal of urology 2002 Elliott SP, Shinohara K, Logan SL, Carroll PR
• Origin of urothelial carcinoma after renal transplant determined by fluorescence in situ hybridization.
  The Journal of urology 2002 Master VA, Meng MV, Koppie TM, Carroll PR, Grossfeld GD
• Utility of intraoperative frozen section analysis of surgical margins in region of neurovascular bundles at radical prostatectomy.
  Urology 2002 Goharderakhshan RZ, Sudilovsky D, Carroll LA, Grossfeld GD, Marn R, Carroll PR
• How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor.
  The Journal of urology 2002 Penson DF, Grossfeld GD, Li YP, Henning JM, Lubeck DP, Carroll PR
• Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE.
  Urology 2002 Grossfeld GD, Latini DM, Lubeck DP, Broering JM, Li YP, Mehta SS, Carroll PR
• Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging.
  Radiology 2002 Coakley FV, Kurhanewicz J, Lu Y, Jones KD, Swanson MG, Chang SD, Carroll PR, Hricak H
• Surgery for prostate cancer: rationale, technique and outcomes.
  Cancer metastasis reviews 2002 Downs TM, Kane CJ, Grossfeld GD, Meng MV, Carroll PR
• Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression.
  Urology 2002 Grossfeld GD, Carroll PR, Lindeman N, Meng M, Groshen S, Feng AC, Hawes D, Cote RJ
• Expression of Deltex1 during mouse embryogenesis: comparison with Notch1, 2 and 3 expression.
  Mechanisms of development 2001 Mitsiadis TA, Gayet O, Zhang N, Carroll P
• Health related quality of life differences between black and white men with prostate cancer: data from the cancer of the prostate strategic urologic research endeavor.
  The Journal of urology 2001 Lubeck DP, Kim H, Grossfeld G, Ray P, Penson DF, Flanders SC, Carroll PR
• Spectroscopy in prostate cancer: hope or hype?
  Oncology (Williston Park, N.Y.) 2001 Roach M, Kurhanewicz J, Carroll P
• Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.
  The Journal of urology 2001 Moul JW, Connelly RR, Lubeck DP, Bauer JJ, Sun L, Flanders SC, Grossfeld GD, Carroll PR
• Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2001 Meng MV, Grossfeld GD, Williams GH, Dilworth S, Stoeber K, Mulley TW, Weinberg V, Carroll PR, Tlsty TD
• Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy.
  Urology 2001 Grossfeld GD, Small EJ, Lubeck DP, Latini D, Broering JM, Carroll PR
• Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer.
  The Journal of urology 2001 Li LC, Zhao H, Nakajima K, Oh BR, Ribeiro Filho LA, Carroll P, Dahiya R
• Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy?
  The Journal of urology 2001 Koppie TM, Grossfeld GD, Nudell DM, Weinberg VK, Carroll PR
• Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging.
  Magnetic resonance in medicine 2001 Mueller-Lisse UG, Swanson MG, Vigneron DB, Hricak H, Bessette A, Males RG, Wood PJ, Noworolski S, Nelson SJ, Barken I, Carroll PR, Kurhanewicz J
• Is it necessary to do staging pelvic lymph node dissection for T1c prostate cancer?
  Current urology reports 2001 Meng MV, Carroll PR
• Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy.
  The Journal of urology 2001 Park S, Shinohara K, Grossfeld GD, Carroll PR
• Dietary trial in prostate cancer: Early experience and implications for clinical trial design.
  Urology 2001 Ornish DM, Lee KL, Fair WR, Pettengill EB, Carroll PR
• Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology.
  Urology 2001 Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, Carroll PR
• Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up.
  Urology 2001 Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, Carroll PR
• Serum prostate-specific antigen for prostate cancer early detection: total, free, age- stratified, or complexed?
  Urology 2001 Carroll PR
• Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations.
  American family physician 2001 Grossfeld GD, Wolf JS, Litwan MS, Hricak H, Shuler CL, Agerter DC, Carroll PR
• Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database.
  Urology 2001 Penson DF, Schonfeld WH, Flanders SC, Henke CJ, Warolin KL, Carroll PR, Litwin MS
• Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.
  The Journal of urology 2001 Grossfeld GD, Chang JJ, Broering JM, Li YP, Lubeck DP, Flanders SC, Carroll PR
• Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer.
  Urology 2001 Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I
• Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up.
  Urology 2001 Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I
• Local therapy for prostate-specific antigen recurrence after definitive treatment.
  Prostate cancer and prostatic diseases 2001 Meng MV, Carroll PR
• Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapy.
  Urology 2000 Goharderakhshan RZ, Grossfeld GD, Kassis A, Shinohara K, Roach M, Carroll PR
• When is pelvic lymph node dissection necessary before radical prostatectomy? A decision analysis.
  The Journal of urology 2000 Meng MV, Carroll PR
• Comparison of genetic changes in schistosome-related transitional and squamous bladder cancers using comparative genomic hybridization.
  Carcinogenesis 2000 Muscheck M, Abol-Enein H, Chew K, Moore D, Bhargava V, Ghoneim MA, Carroll PR, Waldman FM
• Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from the CAPSURE database.
  Urology 2000 Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, Carroll PR
• Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology.
  The Journal of urology 2000 Wefer AE, Hricak H, Vigneron DB, Coakley FV, Lu Y, Wefer J, Mueller-Lisse U, Carroll PR, Kurhanewicz J
• Management of a positive surgical margin after radical prostatectomy: decision analysis.
  The Journal of urology 2000 Grossfeld GD, Tigrani VS, Nudell D, Roach M, Weinberg VK, Presti JC, Small EJ, Carroll PR
• Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor.
  The Journal of urology 2000 Koppie TM, Grossfeld GD, Miller D, Yu J, Stier D, Broering JM, Lubeck D, Henning JM, Flanders SC, Carroll PR
• Frequent genotype changes at -308, and 488 regions of the tumor necrosis factor-alpha (TNF-alpha) gene in patients with prostate cancer.
  The Journal of urology 2000 Oh BR, Sasaki M, Perinchery G, Ryu SB, Park YI, Carroll P, Dahiya R
• Pretreatment prostate-specific antigen and Gleason score predict the risk of extracapsular extension and the risk of failure following radiotherapy in patients with clinically localized prostate cancer.
  Seminars in urologic oncology 2000 Roach M, Chen A, Song J, Diaz A, Presti J, Carroll P
• Deletion of Y-chromosome specific genes in human prostate cancer.
  The Journal of urology 2000 Perinchery G, Sasaki M, Angan A, Kumar V, Carroll P, Dahiya R
• Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database.
  The Journal of urology 2000 Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, Henning JM, Stier DM, Carroll PR
• Prostate biopsy: a wealth of information when done and interpreted correctly.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000 Carroll PR
• A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities.
  Cancer research 2000 Li LC, Chui RM, Sasaki M, Nakajima K, Perinchery G, Au HC, Nojima D, Carroll P, Dahiya R
• An instrument to measure patient satisfaction with healthcare in an observational database: results of a validation study using data from CaPSURE.
  The American journal of managed care 2000 Lubeck DP, Litwin MS, Henning JM, Mathias SD, Bloor L, Carroll PR
• Imaging for recurrent prostate cancer.
  Radiologic clinics of North America 2000 Nudell DM, Wefer AE, Hricak H, Carroll PR
• Is the use of anti-androgen monotherapy appropriate in patients with advanced prostate cancer?
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000 Roach M, Reese D, Weinberg V, Small EJ, Carroll PR
• Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: a retrospective analysis.
  Urology 2000 Tigrani VS, Reese DM, Small EJ, Presti JC, Carroll PR
• Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns.
  Urology 1999 Nudell DM, Grossfeld GD, Weinberg VK, Roach M, Carroll PR
• Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study.
  Radiology 1999 Scheidler J, Hricak H, Vigneron DB, Yu KK, Sokolov DL, Huang LR, Zaloudek CJ, Nelson SJ, Carroll PR, Kurhanewicz J
• Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging.
  Radiology 1999 Yu KK, Scheidler J, Hricak H, Vigneron DB, Zaloudek CJ, Males RG, Nelson SJ, Carroll PR, Kurhanewicz J
• Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.
  Cancer research 1999 Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR
• Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men.
  The Journal of urology 1999 Overstreet JW, Fuh VL, Gould J, Howards SS, Lieber MM, Hellstrom W, Shapiro S, Carroll P, Corfman RS, Petrou S, Lewis R, Toth P, Shown T, Roy J, Jarow JP, Bonilla J, Jacobsen CA, Wang DZ, Kaufman KD
• The efficacy of cryosurgical ablation of prostate cancer: the University of California, San Francisco experience.
  The Journal of urology 1999 Koppie TM, Shinohara K, Grossfeld GD, Presti JC, Carroll PR
• Single shot intraoperative excretory urography for the immediate evaluation of renal trauma.
  The Journal of urology 1999 Morey AF, McAninch JW, Tiller BK, Duckett CP, Carroll PR
• Cellular proliferation and cell-cell cycle regulatory proteins as prognostic markers for transitional cell carcinoma of the bladder.
  Advances in experimental medicine and biology 1999 Grossfeld GD, Muscheck M, Stein JP, Chew K, Cote RJ, Ginsberg DA, Waldman FM, Carroll PR
• Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE.
  Urology 1999 Lubeck DP, Litwin MS, Henning JM, Stoddard ML, Flanders SC, Carroll PR
• Use of imaging tests for staging newly diagnosed prostate cancer: trends from the CaPSURE database.
  The Journal of urology 1998 Kindrick AV, Grossfeld GD, Stier DM, Flanders SC, Henning JM, Carroll PR
• Evaluation of asymptomatic microscopic hematuria.
  The Urologic clinics of North America 1998 Grossfeld GD, Carroll PR
• Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy.
  The Journal of urology 1998 Rogers R, Grossfeld GD, Roach M, Shinohara K, Presti JC, Carroll PR
• Use of second treatment following definitive local therapy for prostate cancer: data from the caPSURE database.
  The Journal of urology 1998 Grossfeld GD, Stier DM, Flanders SC, Henning JM, Schonfeld W, Warolin K, Carroll PR
• Prediction of patient outcome after radical prostatectomy by imaging: choice of outcome measure.
  Academic radiology 1998 Yu KK, Hricak H, Grossfeld GD, Carroll PR
• Genetic alterations in primary bladder cancers and their metastases.
  Cancer research 1998 Hovey RM, Chu L, Balazs M, DeVries S, Moore D, Sauter G, Carroll PR, Waldman FM
• Epidemiological trends and financial outcomes in radical prostatectomy among Medicare beneficiaries, 1991 to 1993.
  The Journal of urology 1998 Litwin MS, Pasta DJ, Stoddard ML, Henning JM, Carroll PR
• Fertility issues and their management in men with testis cancer.
  The Urologic clinics of North America 1998 Turek PJ, Lowther DN, Carroll PR
• Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrant.
  Cancer 1998 Mueller P, Carroll P, Bowers E, Moore D, Cher M, Presti J, Wessman M, Pallavicini MG
• Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database.
  The Journal of urology 1998 Litwin MS, Lubeck DP, Henning JM, Carroll PR
• High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection.
  The Journal of clinical investigation 1998 McCune JM, Loftus R, Schmidt DK, Carroll P, Webster D, Swor-Yim LB, Francis IR, Gross BH, Grant RM
• Inconclusive clinical and ultrasound evaluation of the scrotum: impact of magnetic resonance imaging on patient management and cost.
  Urology 1998 Serra AD, Hricak H, Coakley FV, Kim B, Dudley A, Morey A, Tschumper B, Carroll PR
• Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity.
  The Journal of urology 1998 Grossfeld GD, Olumi AF, Connolly JA, Chew K, Gibney J, Bhargava V, Waldman FM, Carroll PR
• Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer.
  Prostate cancer and prostatic diseases 1998 Penson DF, Litwin MS, Lubeck DP, Flanders S, Pasta DJ, Carroll PR
• A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.
  Biochemistry and molecular biology international 1998 Dahiya R, Deng G, Selph C, Carroll P, Presti J
• Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-Guérin.
  Urology 1998 Sarosdy MF, Manyak MJ, Sagalowsky AI, Belldegrun A, Benson MC, Bihrle W, Carroll PR, Ellis WJ, Hudson MA, Sharkey FE
• Continence mechanism of the ileal neobladder in women: a urodynamics study.
  World journal of urology 1998 Aboseif SR, Borirakchanyavat S, Lue TF, Carroll PR
• Intermittent androgen deprivation for clinically localized prostate cancer: initial experience.
  Urology 1998 Grossfeld GD, Small EJ, Carroll PR
• Cryosurgical ablation of prostate cancer: patterns of cancer recurrence.
  The Journal of urology 1997 Shinohara K, Rhee B, Presti JC, Carroll PR
• The effect of cryosurgical ablation of the prostate on erectile function.
  British journal of urology 1997 Aboseif S, Shinohara K, Borirakchanyavat S, Deirmenjian J, Carroll PR
• Cryosurgery for locally advanced (T3) prostate cancer.
  Seminars in urologic oncology 1997 Connolly JA, Shinohara K, Carroll PR
• Continence mechanism of the isolated female urethra: an anatomical study of the intrapelvic somatic nerves.
  The Journal of urology 1997 Borirakchanyavat S, Aboseif SR, Carroll PR, Tanagho EA, Lue TF
• Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy.
  Urology 1997 Borirakchanyavat S, Bhargava V, Shinohara K, Toke A, Carroll PR, Presti JC
• Accelerated tumor proliferation rates in locally recurrent prostate cancer after radical prostatectomy.
  The Journal of urology 1997 Connolly JA, Presti JC, Cher ML, Chew K, Shinohara K, Carroll PR
• Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer.
  International journal of cancer 1997 Dahiya R, McCarville J, Lee C, Hu W, Kaur G, Carroll P, Deng G
• Measurement of health-related quality of life in men with prostate cancer: the CaPSURE database.
  Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1997 Lubeck DP, Litwin MS, Henning JM, Carroll PR
• Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.
  Genes, chromosomes & cancer 1997 Balázs M, Carroll P, Kerschmann R, Sauter G, Waldman FM
• Prostate-specific antigen after cryosurgical ablation of the prostate. Defining the appropriate response.
  The Urologic clinics of North America 1997 Connolly JA, Shinohara K, Presti JC, Carroll PR
• Summary of immunohistologic dissection of the human kidney using monoclonal antibodies (by Neil H. Bander, MD, Carlos Cordon-Cardo, MD, PhD, Connie L. Finstad, PhD, Willet F. Whitmore, Jr, MD, E. Darracott Vaughan, Jr, MD, Herbert F. Oettgen, MD, Myron Melamed, MD, and Lloyd J. Old, MD). 1985.
  Seminars in urologic oncology 1997 Bander NH, Carroll PR, Russo P
• A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). Southwest Oncology Group.
  International journal of radiation oncology, biology, physics 1997 Gordon W, Siegmund K, Stanisic TH, McKnight B, Harris IT, Carroll PR, Paradelo JC, Meyers FJ, Chapman RA, Meyskens FL
• Focal therapy for prostate cancer 1996: maximizing outcome.
  Urology 1997 Carroll PR, Presti JC, Small E, Roach M
• MR imaging evaluation of renal cell carcinoma.
  Abdominal imaging 1997 Narumi Y, Hricak H, Presti JC, Forstner R, Sica GT, Kuroda C, Sawai Y, Kotake T, Kinouchi T, Carroll PR
• Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of carcinoma of the prostate: ethnic variations.
  The Journal of urology 1997 Presti JC, Hovey R, Bhargava V, Carroll PR, Shinohara K
• Endoscopic management of upper tract urothelial tumors.
  Techniques in urology 1997 Stoller ML, Gentle DL, McDonald MW, Reese JH, Tacker JR, Carroll PR, Best C
• Can hematuria be a predictor as well as a symptom or sign of bladder cancer?
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1996 Friedman GD, Carroll PR, Cattolica EV, Hiatt RA
• Prediction of focal extracapsular extension at radical prostatectomy: Relative merit of transrectal ultrasound, endorectal magnetic resonance imaging, prostate specific antigen, prostate specific antigen density, and systematic biopsy.
  Urologic oncology 1996 Presti JC, Hricak H, Shinohara K, Carroll PR
• Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate.
  The Journal of urology 1996 Presti JC, Hovey R, Carroll PR, Shinohara K
• Should cryosurgery be considered a therapeutic option in localized prostate cancer?
  The Urologic clinics of North America 1996 Connolly JA, Shinohara K, Presti JC, Carroll PR
• The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor.
  Urology 1996 Lubeck DP, Litwin MS, Henning JM, Stier DM, Mazonson P, Fisk R, Carroll PR
• A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium.
  Cancer 1996 Small EJ, Fippin LJ, Ernest ML, Carroll PR
• Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.
  Urology 1996 Parivar F, Hricak H, Shinohara K, Kurhanewicz J, Vigneron DB, Nelson SJ, Carroll PR
• Comparison of systematic sextant and lesion directed biopsies in prostate cancer detection.
  Urologic oncology 1996 Seltzer MA, Shinohara K, Bhargava V, Carroll PR, Presti JC
• Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging.
  Radiology 1996 Kurhanewicz J, Vigneron DB, Hricak H, Parivar F, Nelson SJ, Shinohara K, Carroll PR
• Use of prostate-specific antigen (PSA) and PSA density in the detection of stage T1 carcinoma of the prostate.
  Seminars in urologic oncology 1996 Presti JC, Carroll PR
• Bropirimine immunotherapy of upper urinary tract carcinoma in situ.
  Urology 1996 Sarosdy MF, Pisters LL, Carroll PR, Benson MC, Moon TD, Lamm DL, Hudson MA, Lerner SP, Koch MO, Schellhammer PF
• Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results.
  The Journal of urology 1996 Shinohara K, Connolly JA, Presti JC, Carroll PR
• Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
  Cancer research 1996 Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH
• Cellular proliferative fraction of metastatic lymph nodes predicts survival in stage D1 (TxN+M0) prostate cancer.
  The Journal of urology 1996 Cher ML, Stephenson RA, James BC, Carroll PR
• Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging.
  AJR. American journal of roentgenology 1996 Chen M, Hricak H, Kalbhen CL, Kurhanewicz J, Vigneron DB, Weiss JM, Carroll PR
• Prostate carcinoma: MR imaging findings after cryosurgery.
  Radiology 1996 Kalbhen CL, Hricak H, Shinohara K, Chen M, Parivar F, Kurhanewicz J, Vigneron DB, Carroll PR
• Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
  Radiology 1996 Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carroll P, Nelson SJ
• Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins.
  Urology 1996 Connolly JA, Shinohara K, Presti JC, Carroll PR
• Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging.
  AJR. American journal of roentgenology 1996 Presti JC, Hricak H, Narayan PA, Shinohara K, White S, Carroll PR
• Intraoperative electrostimulation of the cavernous nerve: technique, results and limitations.
  The Journal of urology 1995 Lue TF, Gleason CA, Brock GB, Carroll PR, Tanagho EA
• The significance of prostatic intra-epithelial neoplasia.
  British journal of urology 1995 Aboseif S, Shinohara K, Weidner N, Narayan P, Carroll PR
• Prostate cancer--many treatments but not enough answers.
  The Journal of urology 1995 Carroll PR
• Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer.
  The Journal of urology 1995 Jaeger TM, Weidner N, Chew K, Moore DH, Kerschmann RL, Waldman FM, Carroll PR
• Anterior bladder neck tube reconstruction at radical prostatectomy preserves functional urethral length--a comparative urodynamic study.
  British journal of urology 1995 Connolly JA, Presti JC, Carroll PR
• Cost-effectiveness v patient preference in the choice of treatment for distal ureteral calculi: a literature-based decision analysis.
  Journal of endourology 1995 Wolf JS, Carroll PR, Stoller ML
• High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer.
  British journal of urology 1995 Cher ML, Shinohara K, Breslin S, Vapnek J, Carroll PR
• Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images.
  Radiology 1995 White S, Hricak H, Forstner R, Kurhanewicz J, Vigneron DB, Zaloudek CJ, Weiss JM, Narayan P, Carroll PR
• c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization.
  The American journal of pathology 1995 Sauter G, Carroll P, Moch H, Kallioniemi A, Kerschmann R, Narayan P, Mihatsch MJ, Waldman FM
• Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer.
  International journal of cancer 1995 Sauter G, Moch H, Carroll P, Kerschmann R, Mihatsch MJ, Waldman FM
• Cytogenetic findings in a metastatic renal cell carcinoma.
  Cancer genetics and cytogenetics 1995 Peier AM, Meloni AM, Sandberg AA, Leong SP, Carroll PR
• The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy.
  International journal of radiation oncology, biology, physics 1995 Marks LB, Carroll PR, Dugan TC, Anscher MS
• Screening for prostate cancer.
  The Western journal of medicine 1995 Cher ML, Carroll PR
• The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy.
  The Journal of urology 1995 Wolf JS, Cher M, Dall'era M, Presti JC, Hricak H, Carroll PR
• Blunt renal trauma: renal preservation through careful staging and selective surgery.
  Seminars in urology 1995 Nguyen HT, Carroll PR
• Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
  The Prostate 1995 Cher ML, Chew K, Rosenau W, Carroll PR
• Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH).
  The Journal of urology 1995 Cher ML, Ito T, Weidner N, Carroll PR, Jensen RH
• Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils.
  Radiology 1994 Hricak H, White S, Vigneron D, Kurhanewicz J, Kosco A, Levin D, Weiss J, Narayan P, Carroll PR
• Primary osteogenic sarcoma of the urinary bladder successfully treated with combination therapy.
  Urology 1994 Phan CN, Wilkinson M, Cohen MB, Dunn S, Carroll P
• Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging.
  Radiology 1994 Kim B, Semelka RC, Ascher SM, Chalpin DB, Carroll PR, Hricak H
• Laparoscopically implantable nerve-stimulating electrode (LINSE): application to the cavernous nerve in acute and chronic canine models.
  Journal of endourology 1994 Wolf JS, Brock GB, Gleason CA, Zvara P, Lue TF, Carroll PR
• The Escherichia coli AlkB protein protects human cells against alkylation-induced toxicity.
  Journal of bacteriology 1994 Chen BJ, Carroll P, Samson L
• Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer.
  International journal of radiation oncology, biology, physics 1994 Diaz A, Roach M, Marquez C, Coleman L, Pickett B, Wolfe JS, Carroll P, Narayan P
• Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications.
  The Journal of urology 1994 Shinohara K, Wolf JS, Narayan P, Carroll PR
• A phase I/II study of alternating constant rate infusion floxuridine with constant rate infusion vinblastine for the treatment of metastatic renal cell carcinoma.
  Cancer 1994 Small EJ, Frye JW, Wilkinson MJ, Carroll PR, Ernest ML, Stagg RJ
• Laparoscopic urological surgery: differentiating what should be done from what can be done.
  The Journal of urology 1994 Carroll PR
• Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer.
  International journal of cancer 1994 Sauter G, Haley J, Chew K, Kerschmann R, Moore D, Carroll P, Moch H, Gudat F, Mihatsch MJ, Waldman F
• Neoadjuvant hormonal therapy and radical prostatectomy for clinical stage C carcinoma of the prostate.
  British journal of urology 1994 Narayan P, Lowe BA, Carroll PR, Thompson IM
• Outcome after temporary vascular occlusion for the management of renal trauma.
  The Journal of urology 1994 Carroll PR, McAninch JW, Wong A, Wolf JS, Newton C
• Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization.
  The American journal of pathology 1994 Sauter G, Deng G, Moch H, Kerschmann R, Matsumura K, De Vries S, George T, Fuentes J, Carroll P, Mihatsch MJ
• Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome.
  Urology 1994 Small EJ, Carroll PR
• Screening for prostate cancer.
  The Western journal of medicine 1994 Cher ML, Carroll PR
• Watchful waiting for localized prostate cancer.
  The Western journal of medicine 1994 Carroll PR
• Nephrectomy for metastatic renal cell carcinoma: a component of systemic treatment regimens.
  Journal of surgical oncology 1994 Wolf JS, Aronson FR, Small EJ, Carroll PR
• Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer.
  International journal of radiation oncology, biology, physics 1994 Roach M, Marquez C, Yuo HS, Narayan P, Coleman L, Nseyo UO, Navvab Z, Carroll PR
• Staging accuracy of magnetic resonance imaging versus transrectal ultrasound in stages A and B prostatic cancer.
  Urologia internationalis 1994 Vapnek JM, Hricak H, Shinohara K, Popovich M, Carroll P
• Adrenal gland trauma: diagnosis and management.
  The Journal of trauma 1993 Gómez RG, McAninch JW, Carroll PR
• Selection of patients for laparoscopic pelvic lymphadenectomy prior to radical prostatectomy: a decision analysis.
  Urology 1993 Wolf JS, Shinohara K, Kerlikowske KM, Narayan P, Stoller ML, Carroll PR
• Laparoscopic marsupialization of a simple renal cyst.
  The Journal of urology 1993 Stoller ML, Irby PB, Osman M, Carroll PR
• Negative repeat transurethral resection of prostate fails to identify patients with stage A1 prostatic carcinoma at lower risk of progression: a long-term study.
  Urology 1993 Ingerman A, Broderick G, Williams RD, Carroll PR
• Rat ciliary neurotrophic factor (CNTF): gene structure and regulation of mRNA levels in glial cell cultures.
  Glia 1993 Carroll P, Sendtner M, Meyer M, Thoenen H
• Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506).
  Annals of internal medicine 1993 Abu-Elmagd K, Van Thiel DH, Jegasothy BV, Jacobs JC, Carroll P, Rodriquez-Rilo H, Ackerman CD, Fung JJ, Starzl TE
• Combined role of transrectal ultrasonography, Gleason score, and prostate-specific antigen in predicting organ-confined prostate cancer.
  Urology 1993 Wolf JS, Shinohara K, Carroll PR, Narayan P
• Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression.
  Transplantation proceedings 1993 Odocha O, McCauley J, Scantlebury V, Shapiro R, Carroll P, Jordan M, Vivas C, Fung JJ, Starzl TE
• Renal gunshot wounds: methods of salvage and reconstruction.
  The Journal of trauma 1993 McAninch JW, Carroll PR, Armenakas NA, Lee P
• Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression.
  Transplantation proceedings 1993 Odocha O, McCauley J, Scantlebury V, Shapiro R, Carroll P, Jordan M, Vivas C, Fung JJ, Starzl TE
• Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
  The American journal of pathology 1993 Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J
• Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder.
  Human pathology 1993 Cohen MB, Waldman FM, Carroll PR, Kerschmann R, Chew K, Mayall BH
• A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma.
  Cancer 1993 Wilkinson MJ, Frye JW, Small EJ, Venook AP, Carroll PR, Ernest ML, Stagg RJ
• Heterogeneity of erbB-2 gene amplification in bladder cancer.
  Cancer research 1993 Sauter G, Moch H, Moore D, Carroll P, Kerschmann R, Chew K, Mihatsch MJ, Gudat F, Waldman F
• The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy.
  The Journal of urology 1993 Foster LS, Jajodia P, Fournier G, Shinohara K, Carroll P, Narayan P
• Cell proliferation in prostatic adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression.
  The Journal of urology 1993 Carroll PR, Waldman FM, Rosenau W, Cohen MB, Vapnek JM, Fong P, Narayan P, Mayall BH
• Fertility and testis cancer.
  The Urologic clinics of North America 1993 Presti JC, Herr HW, Carroll PR
• 5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder.
  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1993 Waldman FM, Carroll PR, Cohen MB, Kerschmann R, Chew K, Mayall BH
• Continence after radical cystoprostatectomy and total bladder replacement: a urodynamic analysis.
  The Journal of urology 1992 Gasparini ME, Hinman F, Presti JC, Schmidt RA, Carroll PR
• Determination of prostate volume with transrectal ultrasound for cancer screening. Part I. Comparison with prostate specific antigen assays.
  Investigative radiology 1992 Hricak H, Carroll P
• Comparison of plicated and stapled continent ileocecal stoma.
  Urology 1992 Carroll PR, Presti JC
• Recent advances in imaging studies for staging of penile and urethral carcinoma.
  The Urologic clinics of North America 1992 Vapnek JM, Hricak H, Carroll PR
• Surgical anatomy of the male and female urethra.
  The Urologic clinics of North America 1992 Carroll PR, Dixon CM
• Detection and staging of prostatic carcinoma after transurethral resection or open enucleation of the prostate: accuracy of magnetic resonance imaging.
  The Journal of urology 1992 Carroll PR, Sugimura K, Cohen MB, Hricak H
• Bilateral renal oncocytomas: management and nuclear analysis.
  Journal of surgical oncology 1991 Wolf JS, Carroll PR
• Magnetic resonance imaging of renal carcinoma with extension into the vena cava: staging accuracy and recent advances.
  British journal of urology 1991 Myneni L, Hricak H, Carroll PR
• Bilateral spontaneous renal hemorrhage due to polyarteritis nodosa.
  The Western journal of medicine 1991 Presti JC, Carroll PR
• Palliative percutaneous and endoscopic urinary diversion for malignant ureteral obstruction.
  Urology 1991 Gasparini M, Carroll P, Stoller M
• Acquired immunodeficiency syndrome-related Kaposi's sarcoma of the male genitalia: management with radiation therapy.
  The Journal of urology 1991 Vapnek JM, Quivey JM, Carroll PR
• Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer.
  Cancer research 1991 Waldman FM, Carroll PR, Kerschmann R, Cohen MB, Field FG, Mayall BH
• Renal reconstruction after injury.
  The Journal of urology 1991 McAninch JW, Carroll PR, Klosterman PW, Dixon CM, Greenblatt MN
• Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses.
  Radiology 1991 Semelka RC, Hricak H, Stevens SK, Finegold R, Tomei E, Carroll PR
• Use of the ileocecal segment for bladder substitution or continent urinary diversion.
  Urologia internationalis 1991 Carroll PR, McAninch JW
• Testicular carcinoma in patients positive and at risk for human immunodeficiency virus.
  The Journal of urology 1990 Wilkinson M, Carroll PR
• [The surgical treatment of renal trauma].
  Vestnik khirurgii imeni I. I. Grekova 1990 McAninch JW, Dixon CM, Carroll PR
• Pyoderma gangrenosum presenting as Fournier's gangrene.
  The Journal of urology 1990 Baskin LS, Dixon C, Stoller ML, Carroll PR
• Necrotising soft tissue infections of the perineum and genitalia. Bacteriology, treatment and risk assessment.
  British journal of urology 1990 Baskin LS, Carroll PR, Cattolica EV, McAninch JW
• Pathophysiology of urinary incontinence after radical prostatectomy.
  The Journal of urology 1990 Presti JC, Schmidt RA, Narayan PA, Carroll PR, Tanagho EA
• Renovascular trauma: risk assessment, surgical management, and outcome.
  The Journal of trauma 1990 Carroll PR, McAninch JW, Klosterman P, Greenblatt M
• Functional characteristics of the continent ileocecal urinary reservoir: mechanisms of urinary continence.
  The Journal of urology 1989 Carroll PR, Presti JC, McAninch JW, Tanagho EA
• Radiographic assessment of renal trauma: a 10-year prospective study of patient selection.
  The Journal of urology 1989 Mee SL, McAninch JW, Robinson AL, Auerbach PS, Carroll PR
• Renal exploration after trauma. Indications and reconstructive techniques.
  The Urologic clinics of North America 1989 McAninch JW, Carroll PR
• Staging of renal trauma.
  The Urologic clinics of North America 1989 Carroll PR, McAninch JW
• Early vascular control for renal trauma: a critical review.
  The Journal of urology 1989 Carroll PR, Klosterman P, McAninch JW
• Ureteral obstruction caused by vasculitis.
  The Journal of urology 1989 Baskin L, Mee S, Matthay M, Carroll PR
• Ureteral and renal pelvic injuries from external trauma: diagnosis and management.
  The Journal of trauma 1989 Presti JC, Carroll PR, McAninch JW
• Treatment of impotence in cancer patients.
  Important advances in oncology 1989 Lue TF, Carroll PR, Moore C
• Treatment options for hormone-insensitive or independent prostatic carcinoma.
  Seminars in urology 1988 Carroll PR, Narayan P
• Surgical management of renal trauma: analysis of risk factors, technique, and outcome.
  The Journal of trauma 1988 Carroll PR, Klosterman PW, McAninch JW
• Imaging the testis: comparison between MR imaging and US.
  Radiology 1988 Thurnher S, Hricak H, Carroll PR, Pobiel RS, Filly RA
• A second DNA methyltransferase repair enzyme in Escherichia coli.
  Proceedings of the National Academy of Sciences of the United States of America 1988 Rebeck GW, Coons S, Carroll P, Samson L
• Primary signet-ring cell carcinoma of urinary bladder.
  Urology 1988 Bernstein SA, Reuter VE, Carroll PR, Whitmore WF
• Detection and staging of renal neoplasms: a reassessment of MR imaging.
  Radiology 1988 Hricak H, Thoeni RF, Carroll PR, Demas BE, Marotti M, Tanagho EA
• Testicular germ cell tumor in patient with Klinefelter syndrome.
  Urology 1988 Carroll PR, Morse MJ, Koduru PP, Chaganti RS
• Fertility status of patients with clinical stage I testis tumors on a surveillance protocol.
  The Journal of urology 1987 Carroll PR, Morse MJ, Whitmore WF, Sogani PC, Klotz L, Herr HW, Fair WR, Feldshuh R, Chaganti RS
• Testicular failure in patients with extragonadal germ cell tumors.
  Cancer 1987 Carroll PR, Whitmore WF, Richardson M, Bajorunas D, Herr HW, Williams RD, Fair WR, Chaganti RS
• Abnormalities at chromosome region 3p12-14 characterize clear cell renal carcinoma.
  Cancer genetics and cytogenetics 1987 Carroll PR, Murty VV, Reuter V, Jhanwar S, Fair WR, Whitmore WF, Chaganti RS
• Endocrine and exocrine profiles of men with testicular tumors before orchiectomy.
  The Journal of urology 1987 Carroll PR, Whitmore WF, Herr HW, Morse MJ, Sogani PC, Bajorunas D, Fair WR, Chaganti RS
• Necrotizing soft-tissue infections of the perineum and genitalia. Etiology and early reconstruction.
  The Western journal of medicine 1986 Carroll PR, Cattolica EV, Turzan CW, McAninch JW
• Improved continuous flow transurethral prostatectomy.
  The Journal of urology 1985 Bretan PN, Carroll PR, McClure RD, Williams RD
• Operative indications in penetrating renal trauma.
  The Journal of trauma 1985 Carroll PR, McAninch JW
• Incidental carcinoma of the prostate: significance of staging transurethral resection.
  The Journal of urology 1985 Carroll PR, Leitner TC, Yen TS, Watson RA, Williams RD
• Penile replantation: current concepts.
  The Journal of urology 1985 Carroll PR, Lue TF, Schmidt RA, Trengrove-Jones G, McAninch JW
• Renal trauma: re-evaluation of the indications for radiographic assessment.
  The Journal of urology 1985 Nicolaisen GS, McAninch JW, Marshall GA, Bluth RF, Carroll PR
• Mitomycin C reused: an in vitro cost-effectiveness study.
  The Journal of urology 1984 Carroll PR, Williams RD, Kim MJ, Dombrovskis S
• Major bladder trauma: mechanisms of injury and a unified method of diagnosis and repair.
  The Journal of urology 1984 Carroll PR, McAninch JW
• Major bladder trauma: the accuracy of cystography.
  The Journal of urology 1983 Carroll PR, McAninch JW
• Microscopic hematuria, left renal mass with renal vein obstruction and elevated serum level of carcinoembryonic antigen in a 56-year-old man.
  The Journal of urology 1983 Carroll PR, Pellegrini C, Hedgcock MW, Stein R, Williams RD
• Renal trauma: kidney preservation through improved vascular control-a refined approach.
  The Journal of trauma 1982 McAninch JW, Carroll PR
• Primary melanoma of the bladder: a case report and review.
  The Journal of urology 1980 Willis AJ, Huang AH, Carroll P
• Primary penile reanastomosis.
  Urology 1978 Bux R, Carroll P, Berger M, Yarbrough W
• SIGMOID SEGMENT FOR BLADDER SUBSTITUTE AFTER TOTAL OR SUBTOTAL CYSTECTOMY.
  The Journal of urology 1963 BAKER R, CARROLL P, HAYES D